var title_f13_21_13648="Flow cytometric analysis for WAS";
var content_f13_21_13648=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F81683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F81683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flow cytometric analysis for Wiskott-Aldrich syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 464px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral blood mononuclear cells were stained with antibodies to Wiskott-Aldrich syndrome protein (WASP).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13648=[""].join("\n");
var outline_f13_21_13648=null;
var title_f13_21_13649="Infantile seborrheic dermatitis multiple sites PI";
var content_f13_21_13649=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F60585&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F60585&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Seborrheic dermatitis involving multiple skin folds",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDp92D0pByxJpScKQfzpVOV+7muhgN2r1IJoUjO0cL2FShRt5pyhAOAMmhANJwuBwDzUWzPJz9PWpGVgcZ6+lOjXH3utDAYBxkAj60Ox5yMehpc8tvO4ZwBS7euT+FICMAlctgCk2Y5B/CpOM4Aye2aRxhRzz3oAQbs4KjHqabyDjjFPO4nAFKw2gdKAIsZbisDxcMW0X410O08Y7nrWH4yQfZU55APNDGtw8KoP7Egx1JNa7Ljg1neFRnQ7fHuc1jeMPEV1ZX32HTNqyxgGaYruwT0AqJSUY3ZUIOcrROmmeOGNnldUjQZZmOAK5S+8a29rOFt7N54AeZGfaW+g/xqjcXWoaxp6QXlySwIcfuwA5x7VnQWhmLROBvXhh3Fc9Su1blO2lg/5y3rXi59TkW20oy20QUFzjDk+mR2rIsNe1TRrxXknkubItmSOU7iB3K55zSzWYsLxJcEA/Kafq0QaAleQy5rB1puV7m6w0FG1jVuPHeyVZYbLdZsc5ZvnI9fT8K7CwvINRtY7qzmEkD9COx9CPWvLbW0D6LE+ODkflW58MX8m61C13ZGFkC9uuK6KNaTlys5MRQjCPNE73GRx3oZdnvTmfpxyKaZAevWutM4rjGLZ9B7Upww4zTRknjpQd2cdBSC4m0HqMGkIXH0pWDEdaZ9KAAlaYFJbpx60A8Ag59abK/zAlsDoF9adwF28/eqMEgY/WnFgDjHOaaxBPIyfShXC5HzuOc1neIHCaVPnoRitLDdQMVSv7QXkJhkJKnqBVWYubUyfCSxxac5Xnc3NbXmcYNRWenJaQ+VCu1OtWPs9Cg7DclcjaTI4AqIszdqtCAAdOfc01kHbFUoC5io3PXNAUHoas7M/wD6qUxgDOKpRQrlUQ4OetR3LjZtA5qw5x0qvJHvHHWmkkFyO2jPWrUbkHB5/Co40YRkKVDY4z0zUyjPU5PtTAe0CSDhdtV2h2A85FXkU7ajnAKnNAkzAnO527Uy3GG9qnvk2uWA/CmQjdHuzn6CgZYI470xgQOgqVRx607YfQUAVGHGajI56VZkjYnAH60zYFHOKdhEaDBqO6jLDpUoYA8dac25geKQz0gA9/yoGRg9qUnAGacFGCWAC/WuYq4owR1NNAOeOaFYY5BApWIbHHXpTsFw43cnmjOOGHHqKXAQAjv+dKWFAxm1Qy8809sFjnpSYLZGcUq5z6kd6QCKMtwOaRgSTup/lk9aYQM4zgUBcGycYxigBj1HNO46Ac+tKvPO7B70CuMCkZ9KxfFCf6OC4IwpxxW8WPPKgVjeKZEMCbslcHI9aTGJ4RBOiW4YbuuK4G7/AH093d3JwWkYscdweld/4XcLo8GBtxnA9Oa47xlAdNvpTDg294GcD+63cf1rKvHmijqwk1GTT6mRoOsXJAtHiDJu/wBZntS6rqI07WYHP3J8rwOh7GsvRXkWYgnj6f1rXu9Nju7q3lumbAO0bDyoNcC1dmeqpe5oTavPFdWsb5+8QDj61T10GzhMDo77RuDAZABq7rGjSi2iggkC4b/WEcAeppsviENplzbLZy3E52xb0jJU49D70+V31CW5zltquzTBaFR8jEj1NdB4Hhey1mCa54kugykY+7kcVd0bwwsyw3l8IkYnf5Kj5lz0DVc11Qjrcw8SRMHBxjkVpT913Mp0vaQaOrcHdu6DpTNwHXmnJIbmGOXICuoYAe9Hleleiotnh3GNuAGKYWJGKnKkcEc0Koq+QnmK7kkAD9aDzjHFWigPWkMIA9KaiguUsYPOeaUgHtz61b8sdOv4UhiHoBT5UK5U2eg4pwj5GKnMf1/CnBSO3FOwFZh2IqJE+Y9atTISOD+AqFDz0b6UxCNH9KbtyO9WADjIGPrTSM8bqYEBUgHjim7c96n2j0o2/QUAQBAAcn8arytwatSngjg1VI3NjJHvigLlcqT2pwiGM4qcRAYyx/CpvK3DgfiaAuUXXB4xToSC2Oc1O0WCNzKKb5alsh9xoAsIuccYFMmiUA4xmpouEHYU6aMMp29ewoA52/QAdB65qnZPtlKnGD2NaGo9CMc+1ZtuCrnt70FLY0yFxlRSOHxxge9PhO5MF+Mdqd5e4cA/jTsIqkHPLZFNdQ3AXn3qeRSoPIH0qAgN1yaQIhMZ3ZOBTh0wCTUu3/Z/E0jDn735UDuehKATgc+lOwA3zDFQbwOQMU5XPX9K5rlEr8jg80DjknnpUBck9xQzc98e1FwJ8j0yBSA/NkdKiJwM9jQN38Ix+NA2Ss/ze1NVgpOSefeo8E9MmnCJ+CEY59aNRXF83B4zg+9O81SSCcGgQMBywx+tIERT8+7FVysV7DS5ycnBpC+ferKJFxhfzp5C/wAP6cU+ULlMKx7HJqpqWny3uxdyqF7mtUsB6UzdzT5UK5Q0/T2tLVYXl3lec4rI8caebnRTNBGHmtj5ijGcjuK6Vc55z9alQA/ex+PNDimrFRk4u54Fp0oWfJBwTmussp0O0YLHsPrWd480n+xdaM0C/wChXDblI6K3dai0nUIlZHBGV5we5ryJwdOep7dCoqkND0B4w8bRuAUAHOPasoWq2dyjxfLG7bSvbmoLbUfNON2E7n1q8ri6k3ZxCjDHv7Ve6OhvVGgloAjN0KnFYetOPssgYjIB/GtC/wBViUsgI3eg7fhXJ65cSzRMMeXF3d+PyFToipP3Wdf4fvVfTbVOD+6A61uKBjKkc15V4U1PZeLayO3l5xG7cbvavVbfmJTnP0r1aU1ON0fN1YuMncCMnpRj2A+tKwz60AkcELWhkNYqOrHHTgU8AdlP40AkfxAUvXgZNACMCRycewqPaCcbSfqal56cCkIDd8/SgCIjHUgAUAdcc07GOgA+tIenX8qAGE5OCQDVeRe6k5q0AOw/OmOpPpQBAuO6kn3p+3PQBaNoJGc5qUFV4JBNMCHbk7eSaJEwoPp61MzkrhcAVXk5oArbo2bkj0pI41LcZYGkdMvnoasRqcDcQBQAeXtHIxTWGRyW/CpSBngEn3pHBxgkD6UwKcidtopqrtHJC49BVhkGehNKIs42rj3NIAjGRxn6mnzKxQ4YgdSRTlTAGWzTnGF5/CgDndTAPzpz3rOjBJ7Vr6l985IrNKhHBx8ppjLtuSADgAVODySWzUcAG0DaTUjIcdhTERMfmOF4PrUXBJwen3gO1SlefmJb6UhH91efekBGY8rlGLj0PWoeewAPvU53qT82KaQkn8J3UAdrtyRup+z/AGuPari2UjZyAPrTltgi5eRF+nWsVDuXcpCMuflVhUq27YHIHrU7NGPuMxOOpFR7jwP6U+RE3FWFAeSTTljRei59zSc+ppuCT3qrAP37RwAPams5J605Y+O2frTHUgcfyoAazHFR5J/ip4Un1/KlKkYxn8qAHRqdpw3P0pQDn5hx70Rkr61OoyB8v4k0ARlQRxn8KbsGfSrOB3bn0FOWNiMKAB6mgCsEJPcijAHXAqxtG7BJY0jx4HIC0COD8bW4uEaOYF4j7V5ZcW0ml3OJAWhY/K2eD7fWvcvEdn51qxAJIrzPU7VZVkgmXgn8qwrUlNHTQquD0KNjfhypC8DoAegrcOpEoFEmCOip2rkbGytxKY3Ewwcff4NdPpyWtsVeGMFs9+c15bdnY9unJySZNH5qRM1ugBY58x+1Ubi23/PdO0znop4ArblmEi79oA/QVTly+TEhd/72OB+NTI0tfc5a+jYMCnyBDlSOxFereDdU/tfQ4Z2I85f3cijsw/x615xfWxYsXO49eOBWn8N9RGn689hKxEN4MKT0Eg6fn0rpwdTllZ9TzcdRvG6PTdoP8JP403Yf7q1ZaPJ/iJ9KQRsT8sZz716p5JXKY7j8KbjjjNaC2sjfe2gUfZ4YxmSQfTNAGf8Ah+tOxuAAFXAbbHyIzmlLtj5IwB70DKf2dnPyrn60vkFfvsqipmZ2BDOcei1CyA9FY/U0AIywDjcWP+zTWKkfJHj3NOCgHGAD6ClYYWgCqwLAkn8KbEuc5HepnUc0sGAjZ60xFeQbc+lV2XBz61ckA6daZtH900AVQoP1qRFx/D+dSldvYD3oIGOW/KgBhz3IprYxwOakwOy0FM9SBQBCQx5GBQoG7ls+wpWAyOp9amVc4KrgetFwBUPUDAocfIeKlReM9aSQZWgDnNSALHPPvVJFzxnitXUk5PArPgA3dAaoC3DGQg+f5aewVvugk1NbK3AVOtZmu67ZaVlGkMtyf+WMWOPqe1TKSjqxxi5OyLpibGMAVVuXt7YE3NxHH/vsBXDal4h1K/JUS/Z4j/BCSD+LdaxpId7biSzdSW5rknjFHZHVDCSe7PQ21jTA2Bf2ufd6tQSQ3K7oLiOUf9M2Bryx4eOmB2qu0bQSeZC7ROOjIxUj8RWax13qi3g30Z9HWerQX/8Aq7lS/Tbu71aIHAYrn6141A00T5hkdG7YOK14df1iGMotyZFGDiRQ361ccXHqS8HNbHp6jk98egp/4H8a4vSfG8RZYtUgaBj/AMtI8sh+o6iuzhljmiWWF1kjYZDKcg10Rmp6pnPOEoOzFx7GjaSehNOxx1p23jO4g1RDAIRyV/Wn9QQSBn0pUClcnLGnFSDwgH1oEQFDzgsaYVY9Q351a5zy3TsKaUGeSxoAr7TnofzpQcHGP1qcouMhD+JppQH+EUAKjnpkCpcqeMsx9KjVCD0H49qmTngsAfQUAAZhwMAdgBQVyeTj+tSDHRRj60oTPPJoArTRpIhRuQa868VaKy3DSRKcZr1NIixGFqK70lLtCJBz2pDTsfOLBre+dG4IPSti13NgFto68CtD4naKdI1W2mAAjmUjj+8P/rVi6fOMhTmvIxEeWbPcwlTmgjejjQYLAv8A73+FW85iwvAA6CqsDZXA+8auQkjuoJ79ayWp12Mm/hAU8nn1rnL0PDIs0TbZI2DqfQg8V11/AdrfMSfpXM6hCSrZHFJNxdyKsFJWPavDutQ6totpeQxAvIg8zJ6OOv61ekmmbodv0FeXfCLVxb6hPpE5+ScGWEnsw6j8a9UKsM8c/wA69ulPnimfO1Yckmiu8cjJliTnvmovJOegJ96vup2Dc2KgdU3csSfatCCDay5ywA9qkBjJ2glnxn8KdsBPEZ+ppCSo5Ix6CgaGMeOgWpLSxub5wtvC8n+1jCj8a7Kx0nT4kSSOESFgCGk+Y81oqJFGE+VfQcD8qxdTsM4zV/DsunafHcvIH+bbIAOFz0we9YTivStRtXu9PuYSTl0OPr1FebAHJDDB7irpyclqJkTJkdM01VK9BzU3lkE47+poCMM9PrWgEW189ABTWX5fmarBRcctTCqj7qn8aQFcbRwctShST8qhR71NhjzwtMKj+JiaAImUjq/PtTT/ALIJqdRnlUz9aXYxznC0AViG5wAKei92bP0p5VQcMxNSRqCflX8TQAqxjKsQPlBA9aJEG05qcL26mszXNY0/SIs304Vz92JfmdvwH9aTaWrGk3ojN1JScgVjXN9a2AzczKr9kHLH8Kw9Z8U3WoOy2i/ZID0PVyPc9qwViLPubLE8knkmuepjIx0idNPCSl8Rtar4ou7tTFZE2sPQkHLn8e34VzwiJJI5zz161a8oE5x+NWBHgYI7elcFSs5vU76dBQ2KkcR6E4qQRgn7vIq2kQHbNPKHspFYm6iZskHPHFVriFSpIIrUCknpjPHTrVeVUYkEDikwaOle0VWOen5Gg2xVeD7kegrrf7N+1SFkMPkdevOPaqN5pIjJMR49cU7M6HBLQ5maAFSW/Sp9C1y68PXXQzWUh/eQH/0JfQ1o3VjIh+UblPOayLyABCSCV7VUJum7owq0VNWZ6BB4u02SNZPLulVhkHZu/lWnY65pt7KscF1F5pPCP8p/WvHrTUJ9Ld0QhoG5KEZ59RWdqmtN5xaS1lUHoycr+ldixUnrY4pYOlbezPotFkwdxC/TtS7F6uM/1rlvhfeS6j4Ns7i63SybnRS3dQeOa63DHOAFHSu5O6ueXJWdhhXAyIunrSYY9WC89BU4jLDBye1PS1z0UZ70CKbKvqWpmwY+4xrSaDb1ZVprIn98sfYZoC5RTaf+WZP1qwsR/uhac8abC4DKo6szBQPxrIu/FGkWDFZtTgLdCseZCPy4pNpDUXLY3I4AMF/51Y/dAd/wribnx1oKIW866nbsqwkE/ia569+I94QU0qySFT0e4O9h7gDis5VoR3ZpGhOWyPVS8mD5aYUfxHoKw9S8S6VYuUvtas4mXqqvkj8s145qur6pq0h+3388wbqm7ao/4COKyHtVAwQMVzyxa6I6Y4F9Wdr8SfFHh3V9HNpZ3Mk91G4kSVYzsz3XJ9RXBaa6tgxsTk9qbJp6M+4jj0pjWwj5QY7ccVzVantXdnVRg6OiOjtJe2STWlbsduBtOD97PNclZXlxC44Dr/dY4P4Vv2uowOy73VGPUNxWSi0dsKsZI0bnJUljn0waxNQjY5yK6APbuv8ArY/YbhzWXqEY3cOmP94YpOLLupI5Uzy2N/Bd25KSwOHUj1Br6C0y9j1LTra9hkBSeMOMdvUfnXgt5CHzsGT7V3vww8Q2mm6NcWOszLbiF98JbJ3A9QMehrtwk+W8WeRjad3dHpG0H7qk/Wgo2MIiqPU9TXOzePtCjA2S3EnH8EJ/rUDfEDRHUf8AH5n3i6frXb7SPc4fZS7HSuCPvOcVGeTgYHvWDF410GXhruVPZ4SK07XWtJvP+PXUbVmPVd4U/rimpxfUXK1uj0Hw7Ks2kwdd0eYzn26fpWoFJ6DisL4fMtzNdWwdSMCRSpBHoa7n7JBHwxy3oawmrMEr6mRFAxI4JFeZ65bi0168tG4MbblP+yeRXszTQxKAgyR6CvLPidCI/EmnamBhLqJrd8dmXkfof0p0XaVhtIwShA+8KTCjHLZqUhT91DSgMP4QB6mukkYUD42psb1HSmSQuoySPwqwUz958fSm4RT0JNAFUBPUmkI9Fq00bNyqAfSo3iOPmcjmgCDaxHLY9qAqKOSTT9qqxPL08DP3Vx9aAIsf3Ex9abPJFawPPeSxwwIPmdjwKz/EeuW+hQKbg+bcyDMcKHlvcnsteZanqN5rU5mvZRsB+SJThE+g/rWNWsoep0UqDqHR+IfHU0m630JTDHnBuX++3+6OwriWV5XaSUs8jcl2OSatwR5fBGUFXAqMAAFwRx9a86pVlPW56lLCqK2MuKIEirQjAjzxmrAtAdxVh0pi8ZBVc+tYXZ1cnLuRoCvVefSnrl/ujGO5pVGGIz+NSKPm5IA6AUhWFVBwW6U4Bdp54qdodgBcrtHoc/pUOd+ckNz19KpK24ctivKBngcjmqkuN3TNX3jOODlun1qhMdx+7jmpYmjubDVGhJy49uxFag1SK43IXIOON3TNea2PiC0aVkumKk/dyPvH+lba6nbAbUTOfeqs7GylFvU6ZJRMhV22uPXv7VS1WzcxLhCVIPAqK2uwvJTKMOPUVcGoJLlWNTF9wmuqOQvIM7gy8kcmsyJTG5RgSh7V1WrxcmSMgIevHSs6awMqiWIbRjqDmtIy5TmdLmZ1XgvxcmnW8On6kn+hJxHLGuDGP9odx716fDLEyI8CmRWG5WB4Yeo9q+flG1W3cN7VteG/GepaPPbw7muLJCEa3Iz8uedvoa7qVfSzODEYJ7wPbTLL1VEX3603Er/ekb6DiuU8ReObS1VY9HxOz9ZpB8q+2PX61j2PxA1QFvtFvYyqvO7aVIH4Gt3VinY5I4SrKPMkekR2ylgFUsx9s1y3i3xjaaGXtbJUub5flYZykR98dT7CuR8U+M9X1GEW0DpZo33hDlS3sWPP4VxPkskgLE7hz1zWNSvbRG9LBNq8zU1jW7/Vps6jcvMw5Ck4Rfoo4rLZGQhpl5PIGcU4HLlm/L0qRE8xsk8Dua5JVWzujRS0RGiFyM8k1e+zRpAS0gLkdKYiZI7YqUpuUnPC9qxczojBIrhMtgc/SkZBgk9elWcLnKqCcVHt5wDn3qLlOJVdcnPSq8se4n9K0Am85bseKa8fJPGaLkOKM4x7F4HPY1X8nLEkZ71pMgH/ANemxQqSCzEDPIFXGTM+S5QEYVRxwaQRn0q+yZc4+g460eTsABGG781XMyHArxxbe9PEOT0qysWAc4x608rlMnGPalzsagips25xnNRMhDfWr2wntUbL3FLmY/ZlNo/vZ5NRGPj5hn8KvFM0zy/T8arnZPs0RwXNxaTLJZTz28gH34pGU/oa6XTPiR4t0zaI9ZmnjH/LO5AlH68/rXP+XlflySKgki4JHb86pVGRKinuj1bSfjjqMTBdY0i3uQOr27mNvyORW1rnxI8K+I/DzxLNd2OoQus8MdzF8pYHlQy5HIJrwiROe+TSMnz8ZxitY1mmYSw0Xse/aTMNYjU6bLFc7h92FgW/LrWi2kXw4aGU+wGa+bx5kUolhd45F5DoxUj6Ec10+kfEPxXpcaRRam08K/dS5QSY+hPP610rFX3OeWFktj2R7G4ThraXj1WmGC5Uf6iRf+A1xuj/ABrvwwTWNLt5oxwz27FW+uG4r0Tw74/8O68wjtZ40uD/AMsbgeU+fbPB/A1oqylsYypTjujK8uT+LeB34phVAT8pJrvRLZlsMpRvcA1PDBbTnEcsJPo2ATVe0Mzzrn+FQKwvFevx6DZjJEt5KP3UY6D/AGm9vbvXq3iU2GgaDd6tqSRmG3XIUAEyOeFQfU18taxeXWtapc390wEsrFtg+6o7KB6Cs6lblWh00KPtHrsLOz3sstxeSM80h3O5PJP+FIIeNpf5R0wKhhQqFGPZgTVyNA2SAcjj6V505N6nu0aK2REqhJAEfA6c1Kdg+ZTuPXBFTRwpIMAj8qe1oei9zwayN/Zsh8wXRIbaHxzj+dNMQaTa7bR6g9PentbeYV3EKwP8PFI1lIqbgSdmSCTjH09arcmcX1RTMjJKQnXpnHWrGzMeeS2OCap3rN5K/uiHXkOOc/h2osrszJ8uNy9VPUUWsZ6bFmPc5AT73QeoqUptIPIOTw3UVHuXYH2EPu59MVFNMFLMOQ5yOeQKGBJI24Hjp0qpcOrDpll447U2SUso5G3njPWqzT8EbVGenFSZlez0GMxOZUB44NR2UMsV4YySUXGK67SwGjcuPl6Ae1U7a386eS4wCu7j2AroqOOyNYYd2Uu5bsGIbazEZHH1rS2fJ5hx74qraw5cEAcc49a1dqrEySYHGRXK7XubQ7FG6BMJ2k9OVPpT9FP2mzeNTwjYP09KVwXQ4HzD37UzwyyxapNAcBHXcO/I61UXdWJ+GaZnarH5Mp479qzdOXdqMhOeFwK6TxJEqsdvFY+hxK95cMw52hQatPoaumua4zUdwifkDAzgd6vWJ8yGPgFmAY5qlqzbEIU/Pjbx71o2CCK0DMrF9oAwauD1uzOrGzshbuMMwBzz/e/nVOQFcqpUkj739KdKZpJHYj5h2HapoLYMpy5JxnHvUSldkqGlikkXzAMdo71YX5UC/wAI7UkyiOTanTGTk0qxSSAngCszPld9B6FSMDNSFkAHH4VCMKWBPPqKbkKp6ZPQ+lINiXoMcDPemE8c4zTckMMfjQy/KCG5zjHtQG44OAeOfb0ppOe3WpYUQnqxx1B4xTLmRDtMSFR6nvQ1oPl0uQuoyBnpzTXAzgDr6Up69c+1PYhvYCmtiL6EWzuAc/yoHB+Yc1MiHOTzml2Z4oISGggYyMDtRkcccVMqbcetNI9AKBoZj2xTCO+OvpUjJy3IJoAIzQNplZgQemaYPXFWyB1xg9qY6enBNCJsytyOgqOY856mp2ByQoNRmPOCRTQWKbghs4JH9aRgAOuCanudmemD7GqkhAPIwO9MTJOQMkA5HWq80mx+ck46dqfG+QWB6dqTTtsru787j19Kd7Ey2sVJDK2dka++eKjs51uGeIgpMpztJ6e4rXbRbwp5mFMTcrluSPWsW+t2sZY5+Ayn5h14rZvQx5XfU7/wr481zRPLhuG/tGwT/lhMckD/AGX6j8c17T4S8aeHvEkIijdbO8Az9muCEfjurdGFfPEADxKyAYYZHuKdPbqUyR+GORVRrNaFVMDGSujvfip4pXXrqLTNMm8zTbRixl7SyYxkew6CuDWORABuH1HBqKGZoTtlO6P1xyK1YYt67k2sp/iHSlOXMdGGoRgrLcoKrq2duSeuTUoZwCNuPYGr8cBbgqM1J9lGDkAH2FYtHoxjYpwyED5kP41eicMMA5I7dxTksA3dgTTzpz/Kg2lierHpQolO/QUW4YjBH41KLUKV3LnbjAFU5FubUtvBIHbHT8atWmpIdsbEg+h4quUyk31RHe2MQYtCu3vg8En8a5u9sik3mxtslHQ9j9a78Mj2xG8OuOpwCR6VzuoS2Zcp5ig9CM0Sj2M04NWZi210lzmORNs4x8p/p60y62pcOjqUHcHsai1KzyRLEcOOVYUlpcrdqY7kYlQDOevHce1Re5E1bRkbJIVXCNy+xDgkM3oPU9OKq6iYopvLj81SFG/zl2sH/iGPTPSumu47W+02ySLVYbJ7RNphnyq5JzvUgHJI/Hiue8U3cd3febBIbhUiSIzkYMrKMF8e9KxzO502wwaWcnbJMQkf17/kKttapbwQWwU+Z1bNXNHe2uWe6uw32eyiK2qEcs5Ocn6nr7CpLCE3M0k0gJZjwe1aNHo1anRElnbqF+6c1FcKPM5XPoSa2kh2xfLxnp7VAI1Aw43Bj1PWs5RuRFpIxpI28s/Tt2NZ0D+TrVqQduZNpx71t3rrA2wEFT6VhMN+s2KrksZQee9JKxE+5reJIzg7gOvBxWToCEi5YeoB/KtnxMxBcltzAfhVDQQYtCurtjjMu0D3qo7s2T2uZF6vn36RqGwDuP0FaYDBRIcL6KP51VhGHZyvzOevt6Vox4UKr/ljrRzdAcU25ELQtGdzLywznrioWO0Yznd0PvVueXegXG0DqRVNgN2ccDgVLZnOdtERdfy6UFyIyqsdtNYZ4BP0oC7RzSOZyb2EBAzihmIUEg/jUqKD059aawyBkcDigFESNJJclQMe9IrrnafvZqTG1Tzk+gPekEe3k/eJ9KRdtBDk9KZyT83Ppz0p7OAAvbNIFyfl6UXBpoEUK3y9AKeigk560BcAnpTkOcDr9KCbXBhgDjikA+bPOPSp06YA5pTGSSfX0ouaKKsRqGJ4FLtxkCpdozjg/WjYBk/yoJ5SEp270gRScAdOtWApIw2CP1pNq7R29aAsQOmw8jrzTHXJzzmrQUg89fY1Fs7AgHvQhtFIx/MAOtMcDHpjjnvVzaQelMKglhjDdBQmJRM2aPLnjBqBoN27J7VoPy3UDtUDxYIXpn06U7kuBkSRFSWBz0qTTRtkKHGScg1bkiwMYOQeuKYVBYNjB96rmMnCzLzpKrbFyuOM56VzniKQKhYjJ+79TW75rqMbm6Vj31v50qsx6H8qIsU1pobGkAJZwox3uqAH0zWgyhk+XhqyNOkKR7H4UcVqEgKr7sdiKs6qbvErum4kHFQ2rSw7vKbBU8jsR71ddM4I5aqsPF2wI6rVEyjqXba/Z8quC/cNwa0EvwCC6MvvnIrnbw+S6yoSCv3h7Vt2jB4wSDk+3Slpc3hz20exrW1zbynKspYdBnmta3WJ1VpFL8cAD5vpXLSW6McbPmPRu4qpJPc2uGgncEHpnIp7Dc+6O0ntoJEfyoysXo/BB9q5TXIhbsijIds4z2Hem23i25RyLiFZP9pWKk/WsTUtXmvr8TShQF+VUU8D/wCvV2MJ4lJNJkcwD3v76aRwmPvGtVo4ZbFwPlXHBxyaz3tvNjW8hIbj94g7YqpcXx8tsLk+lbLuebez1JtMkcXUtu0gdCu9M9Qc80+9tQW3qdrjkMO1cedTmt9SikBKg5GT3Heu7tblMwztFHMuAxR+VbI6HFctVe8duHmpwszQhuNUbSdP/sqaygxERNG0kauX3H5ju7EY+lct4hmu2vT9vljkutoDNGVZcY45XitS/wBTgSTzo9B0tmHXKtyPzrBvbqC8uDNFbQWqMoHlQghBgcnnvUtX2IatudvDIWRYY+VHSun0/bHbhG4PU+1YmnwJF87ZzWmCXzzx6Ur9TsfvPU02nRBk7sHABFQ3hURiRfmYdFA5PvVERs+Sz4PZancGO2CswLZ5we1CY2rGXfSAnjp71F4Tthe6+9w3zRWqFjn+8elZ+s3Xlu+z5sjAUetdPoludH8NsJiv2mc7pOx6dKEuoviaRheIZ/8AWE8L1IJp2fL0mzs1yAqeY46kyHn9BisrWbhrm4WKM5LHqegHc1q2wA5JJY9z29c+9EXZM6ZRvJdkLHbqihicEjP+feiUAQAqc49qV3GPnbgdKryyluowB6c5qDOc0tBjnAGDwBionbI2jgdcZpGO44AJ+lSRIMHnJoOR3Y0IcArTzHyB19R2qZV46ChiMn0pNhFWI8EHgdaR0OSO1SoQCSMHipAM9eKkpJFdUXOKWQDzBUkikH5MZ6UrR8AqB6UykrFe5XhTgcjAx1psW4AVOy5fnoBTVXj5QelK5UveGMeQTg+1PizuYgfgKesO7PPHYetSxxkn5TyelBKVgUMozwPwqRTlSGxzSqCDh+ABgEVMIgMEA49x1oArmHPI4x3pWU/3QatmNc4wStIiFuFwCemfSmIqCPHL8e9DxjsevpVryj1K4b3pgTDE7QcCmMqsvz8HPY0MgyCF6cD/ABq4y7s4G0EUyRcHkAe5pCKBTJKncffFRsu0MCOc/jV+UnAAGEXk5qvIFOAx3ZNMZSSE7S+MnvVaVMMWA4FaYOxcr15GCetUmXjOOM9+KQ29LFSVNx3ZIBqJIzjjkDGatyLk49OntSFMBs528UyGk3crSJtYhjnmmLAZHJA565qw6YIAHvk1NAGDFkPTH+RTRUKacio8Cw7W6Z9OeaugK0Hyt83rTLoowK7geN3Wktd2cFc9vrVo05VFiRhmVgc8cVAg23sfbg1blIH3QVOOaqsQ19Gc9FJqkyZR1C/UNC46gjv2qXRZi8Ma7iBjGT6imXfERz6VDonKMrD5dxxUy3NaV4yaOoLhkPTPYHms69tyVO1cD29avW/AySSMdPWpdqPH83CHqev+TVpg4XOKkJE+xgQw6gUSWjKHcqWjY5IHVTWrrGn5dpIfvA8GqMd9sXa/DehPeqTOGpT5dJGULmW0+aF8DuCazr7WkRy6IUlwcMq7gPU8Vq3SwzSbyoO08r3NVTGCpU4AP4Gto3OGp2RjWKm5uDdzoWTorOPmcnvjsOwrftNRFuogmH7v+FwPu/UVWlOAUTHtVRl3EsTwQDketW4qSszOE5U3eLOkWGS7KLbxvK0hwgRSd59vWoJbGKK7WKKyvEmJEbo53Evjn5ccf4Vc0jX4bXSo2ja5V4LU2giWFikDO/zTbxxyp6da7nw5bJqnjCz8hpXjtrY+ZLIMM4VdoZh1GST17Cs4UrS1NamI5oXKaxlWA6gc1dtpRjk85xg9KjmlROuBVK4v4o1ONu49hXKos9VzSRpyTLuwSM9zmsnUtQKrhJPlHByazGv7m9lMVjbtM4H8PAH1NaVhom91uNZkVgnPkIPlH1PenYSblsM8Paa1/dLf3WVtozuTPG8jv9Ks+JNYDEtlQAMZHf3qHWtdEURjhAVFG1VHpXJ2rNqE7SyEm3Q8Z6O3p9KT10RrBez1e5q6cru3nsD5r4wD/CtbQfy0YvyOvTrWfZkoMnG48k1aklLxEbe9I2cklqRO5xjdz6UzkEHjJ6Z7VNIAQOi4HaowuGyRxipOSe462zGh+XLEdfSnIh696cgx709Ru7ZNBDYh4784zis7Ub9bdWCnp/OtF14OBk1zeuQN5hYg56gDuaqEbszqSajoKNUkV1VwBu554robOXzFIIIAGT7VykgkupbdXYMVUYI5wPSup06EpDjpu/KqqQSehNGTe5dQA89wOM00xiPnJ37u3Sp8FDGCcbxkZFK6HODgEevNZWOm5TeMswxnn2qYR7V2jLZ6cVajQDtyOCetSbdsoKkkgdu1CQc9tCoIuoYfN046VIqgNg/pVhcbGySxz1x0pVUMB+FOxN9dSARuzEhCcVYkB4O7Ld6lMZ2gDjA/rSkBpBgjim0DkRqCQSAeBzxTYYjjLDKDqCf0qzsBVlAwT+tOiiwNrc49aSRPMUypD4YEMfujsBTliJ3BducZBNXJIzjOcgj1qGWMeWfvA8fd701EGymqg8v1zSMgb7rA57elWChKkt8q55xyaai4BxnBGBRYadii4ATBT5j3zmoHUMCo6qOtXvLZ1YBQcDJzUM8Krs2Entg8fWm0UijKpGAuWX9c1XlBJwpPsD1q0WPmOpJ49KY0YLO4YAqMgj1pWDrYpbWONvIIzTgu8qG4/CpmGELEHtUZ4XpwcHNKw2khssI4dSQCcAGkRY1yDnJHHOBSyO23HJwfvZzmmS7tpzgg9RjvTsbwkivMpDHIBJ7DtTEl2MOoJzx6VOJUGAFIb7oqLZ+8C7QMcHPemTJ3ehKrZI5HqKq8NdEkYKrzVhSFGVILe1QwoGmkOeelBdrjLokx85xTvDqF9/IzuNNvGCR57AZOea1fDVt5dsJG2qMc57k0FxjeTka6gKFUsAD+tQNMwOARgcDIHSor25VV4xnvWNNe5kKJuz7U3LsaKNldl66nBOAefeue1KFXDOApYdR61eaOaTHIX1NH2UDlhlumT3pwTTuY1uWpHlSOdk3Bd6bnXse4+vqKhmmwdkkbr/dbBINdX5CleV49BUUsEe0kjOPWulVFseTPCta3OPedYpP3j9ex60NKGXAbkrx/n0roLmGJwVdEI9xWfJplryVRlz2DVXMczpPoa1q323w+ba1vbaGP7C8D280wiIm8wNvOeoI79sYr1T4UXlleWV/PBdC71GExW9zcfwy7E4I9s5574rzqKyb+ytMOm6LZ6iGjIlna1Erb9x+RvTAxz3rTmvbjQ7fVm0eC204qsEZe2QD96w+eL0JXrnqKIVEnqZSot7EbyTSDA7+tLFYxMd1zucDnGeKqm8VFyvzGoJtQcocfKT39q5krHq81zpBqFvaW/lQIqgDog/rWHqetuULbtqDHesie4kkYJECx7kVUjt3upz5hyiHDnsD6Cho2jU15YjJBc6m425SBmwW7t9K27aJI9sMagRxDAx61HCAImmAARRtjAq3ZqVXOcevvS6FrSRbjJCkEAsTmpQxI2rmoRk853HPNWVU7gpyf6VmypJyGEAYGOfWkGT64qWRABlVPPTFIUIcbgcUjJxaFChhkcU9c5yaI+RkGpVGCpOM0E26EiKDgN09qZPYo5BIBB45qWMgMQeMenepty9SfyqouxDVzPTT41YlECkd8dfpV+1tftNwIUbbjPHTNG8A7R0psF0IrleQFzycZ49afNqOKsyQwSRTtC6kupwM9uaam92KKeScZpLmZZpl8vPyghmyfmqXTArGSV3IXcFAHejS5py3Y/wAhUkCkNwMjJ6+9DghmJyAR29adezj7WGbg7eh4pwwq72J5/Kk9CZLUijALnnk/rViJAQQRwOKiAC7TwOvB9KlWQqQO3tSuQyRsbDzhj/Kmjsp4I56dqYzhsEj9aaSW4JHX16UXAsRONrhQeverEOGJ5yRVAMONpJIP6e9W4psYA4A5+vtTTEy3OCiYGG4qnlQjfeI6EAc/hViWQNHxnJbGB3qIErISSMDpgZqyU7FYLtD8AKeQM8/SoZNuAyg5/wBrpVqZVXLEjJ6mq8/ysGJxnGMdqVik7kUKYkcB1BVdwOM/h9arzOd+GAJJxz2q0hVDnnk/dqjcKPlDbVC5IxQaXRVdGc/MVGPWogC4OMegz6VLIQfTGOeaYMFSF43HjP8ADUMLjAFWHEjYiHrzk1CR90YzgZ69qc0i7X24KgYBYVFKWQgjOQMc88UIvdKw5RI2UOAiH7vf6571G20FipAIHAJzuNNWQ4ITKg/y9KZ1yWOBngelMald2FYfOOCMnjvTLlViXD5Y9Q3cH0q15odU3EAKDyR933qu7K+SQMg9Ox96DRogjOwDIPPXikD7QW24NE3C5LAZHH1pr7ggO08Chji7aEcwMhSL/nowH4d66mZktbRUTaMDtWJpMIkvS752wLxkcFj61Y1W4aR0SADexxx296HodFNLluyhOZLucxxHao+8/wDQVdtrJFQccDrWnpOmKkKEj3HuafexqpKgjGOgqoxtqRJ8z1MlsCQY/hpNmTu7CpTHgksPxpkpKnHbtRq2N2jG7I5CBk8fSs+6LkdcVak55wM+vpVKfcZevHrWl7Hm1J8xWxuHyrn3PWopAQScZJGK00i+QgY461FLbnbuPT07mplK5lyaGnp1rZW9mm61uprmWye8Z47lolfacFAF9BWbq9pDBfJ9kiMNpNCk0UZckgMOpz/F61s2y21hZ6c89zqJkKtPGLcqEiJOCBnvxzWbqkqXd/JOkk8gYD5p8b8/hxj0pcxkoamcGywwGJz0qcwkg7m4PHB6D0qaKPYN0h796ZcSYB2njFdLiODS3KV05QpBbYEknyjnoPWprtvIjitLY4YkJx3J6mqmklZrs3D9Pup/WrCLu1rLg4QFv/r1nOLsb0ZpXZoXS7fJgQfKgzU8Pyjv16Gq/wAzuX5GT1/lUyxqcEDnPes5mkW9zQQo4ABAOO/apoyRGWVxjrjPNZnlAnGPqBxUoiLEZdvTjisjVVGzQDldiFsjsR0qYugcs+7fnr2rPBnhBLbZEPylehNNlZ2cNZjzVPWJj8w/xp8pT2NBtqgbSvQnr19qkRl3YJBHasWC/Bfy5DtYfwEYNXIbgL159Mdqmxm0m9DRkA+8GANVzKUXYFByc5qAysxBz06kc8epqNpAd3zfN0Ax29aAs1qWfPAY889KimmVJNv3sDnHrVVpMnB5IpAQQAeDnrQCaNG3kdgCFOB1zTlco+0Harc+uahjkCrsTJOOucYNCuQwIGCuOM96DdwUfeRcRv3gd8565I61ZRgcj/Iqgjtu+bJNWVKYYLwevPegxaurkzyKhG44GO/eiGTG7Jz6VWlyy4Py4xg0xXK5DEde3eghK6LcjkMOh56U8lSAy5G7v71W3kICOfUZpqkjnOV9KCS2j5l+UHpzjvU0R+YHnHTPrVBJFVcch/73+elWYXZQASRxgHuKZTVkaaOAhCqcH8zSq43YJxu5Ge1UUY7OTk9etO35+bJx6mq5jFosSSL0AJX2PWqztuVVOCxywY/ypjl2ILHofzFRSy/Ngc8d+wouUkLMdpB27SfTmqc5yOf/AK9STTZYH0qpLI2DnAI/X2zSuURSEYI/+vUbNgjP0+lSFgMliOnSq7MSScZBpCYj/wB0dOuKTcuw8svvTHxuwGDHHXsKrzMTheT6jNBUZcruAwuMfXnvT5GVowAwDg9MVG6kxjOeO2KIogTknDfzpjje9wjEmcfNgj0pyERgggc8c9asJuVcZ+f3qF42ViygEAYyOao3tYqzKHkUDOetPyQSX+pqeJGwSw6fLkdvWoxAbm7ht485kYDHt3pDSt7xt6ZGtpoZmlB8yYlmA9Kj0Oxa7uvPlH3ux9Kua8Va5h06AKIIuu3+v1q7ZL5UfykKcf5NO13Y3jflsi9IscShEChgOccjFZrpvYFmUqOSQOT7CrE8uIxk/M3vyfrWLeXJUbc457Vonczn7upJeLGGOxgW+nSs2cEZP3t3XHY07kox+bcetQyPhgB1Hf0obSOapKUtWRsFMTkk5HQVWUDccA1YOAM+nJ4zTVH8RGBWUmYvUFUAc8+9Eqb2HygGpIzg56+me9WIdsU0cjQpOFOTG5+VvakGxrWj3K6VZLYajY2qBD5kTuoJfJ+Y5B5PFY2rLO1+xu5oribav7yIgqR2HAA4rVS8tT10exBHu/8AjVK98qaV5I7eK2AAARMkfgTTtczSszxOHUdTidWjuZuOAC2RVxdf1ErscRyZ45Wvpa8+HmjSnzJtNhBxzgVJpfgPw/DMrx6fGWHYJuNet7F9zxFUt1Pn3R08SiBtQisJHsV+8BCQv145rptIu/7TU3Qt3hdflcnkN9K+lIoRY6dK6wRWtpFGWdmAOFA546V4Pc3C3d9PdFFQTOXCKoUKD04rGslFbnbg7zl5FNEJ6jbntViODf0JB7CmNIqH74T0GMn8aja4n2hoypI6ErjFcDTZ6d7Fz7PIBjbkD0piSbWG1ixB6EdKqreak2VESE9wDVqOedx/p+nuw6B04I+hqVEuMWy4jrKec56ZNOls4zyhOcZBAxiq0GoLEfLQq6kc+YuHA9K0VlWZUEZwRztxRY2UJdDNuLZZk2TDfxwx6j8fWqDrNak5JeIdD3H1rtJ7WOWPeGYkgZDD261k3UCquGHShtrc3jSUkYkVxkEqflIwT2qxEoKgqTuJ7dKqXMDWp82AZHV0H8xWjpU6TPwVJboexp6GbpNO0iCaMqwYcjHX1psWQuAMn3rTvYNicLgHpWbGSJ9uPvVLRhKLjLQsrhkHYk09Sqqo796gcbV6/MewoibaB/nNJmk53Vi6kpAzjPHNToQwIOTkdqqxsADjv2qRfuE4pGTlfQsuMIFHNQNndgYAPOaesjN16d6Y4OfvdaCQRj82/FKzcAKfwqIlT3/KlU8Zz7UAx4YbtpIUetWlkwBkkj1qmD1xyD6ilRiuFJyBzTBsvs/UqcimibLYJ6DjFQZ2gk5xUe4M2AOO9FxFsyHH1/WoncK5BG3IwADTSw7HH0qMsACeNvcU7iEz8uTgnrUBJ8w7vwFSblOcdDVaRsMSPzpAIecKKikb5eenemysc8cA1ET15pibHKQp7MfQ1Xcgtgjp0pGYlh3PoRUTNs5HPNNISZbeQo4YlTjsP6UyVmUlgoLfebB4AqJp94I2AkkBWzgChwUj4bJLYx61aRu6l9i1DKG+YjcSOg7UmSAVYZOBxnqagikcIGjJIB7VJCHZixI4+Y89+1OxUZl2UbFEWBuAxx696k8OqonudQkH7uBSqk9N1UbpnRFjT5ppPlX6nvWxdR/Y9MtdPjIzL8zkdSB60GsfeY2z3TyyXJb55DnHoO1aSynbgsRjj2qkrBAoVcY61NvGD7dPeoudKQTScNjIzWRMAzY38nnB449annmO47yDn1qsVUuTksQePpVrY5K0rvlBgYxu3AYGAPX3qHDeauAGbcOOxpJn3bj94nj6Ck3naw6HIOT2FJu5zuVyVlKvIGcK5OPLHfNRshVSH6Drj1psZ2Shi2WzTmKs5OT17npUMlgF2soJOO1XLVoEukaeMyQjqgO3d+NUVYhi3Un3pVYNjnHsaaEzr7K1iu7eOaPQyYTnB+17c84zz296ytaiW0vmi+zrbYQExiTzCpx6+vtT7W/QwWglS42SwvYSFUypycqU9SCeRVHX7pXvtiCUCKNIWMq7XYqMEkdqu6MVe579DpSE7rgvKRyd3T8q07a3ijT90ox2wMVbVAeob3FP3IOi5xXq3PBucH8YNRNh4NaCMhZL6UQ8dSo5b8OleF78McEcivSfjvqRm1nTbFcBbeAuR7uf8BXmaqCfkAAHc1xV3dnq4RcsPUUnLHABY9akRSQMoM9c/wBKFBT5eM98VMkTHk9OtcrbO6MW2LGrgh92M+9WtknlFxOQBn+P+VMjtQfmkZQD0JNX7d4FCRTSKY85cAjj6UI64ztoZVxO7KBPHHKO+5QDj6iq0cjW8itBvC/3HPT6Gt0wG5Z/K8twM9D1FULmAodpRUPUrSd+prCVzS0jV4pQo3kc8qeoPvV3UtkyoUYEjqcc/jXH3NpsIntz5co754Psa0dI1pZJBHdgrIoxgnrTSujT2iTs9x9wig4Gfoe1YW5rHUVTP7l+nsa6e7RdoP3gR2rn9QjJhbaMsORntiptYqpO6NprpJ4VBOSBjJ7VSuUKxwsCPvYB6VBaXCssciDqB3pbxd7jBJXt6itOU45zuhwLNJg9B2qZhtVcgY+tQFdojcg5PFJLMSQPWpcTO65ddyyH2kA5x7VPHJwc9D61UU5B7fWgOVwDzWbRm5GgpwOv4UM3r2qvFJ8ozUhIKHJosJSAkbjxSkkAevXFR8ZI5ximkkd80WC5OHGM9z2pM5OeeeBUBPYcYp0bEcZosFycZxjPOO9NEhDfd6ccVEzcdTnrSFuD2FFhcxYeQDkN+I71C8hHJIqIHjGTj371E7kjpmnYdydZN3yk1DK+CajLY5OaZI5bAp2JcgaT1GajL4PPTHQCgkA1Ex5NFiWwLcH3qKXGASOPT1pc5YntUTHk5NWkTcRnJb3PapoyCuXY4XoCarlfu5YFie3anjO7aoBPQEc5q0hJ2Ldoo5JJDAHoeAKsRyKqg56c9P0qkoJcpxuP6/8A1qll3kLBGP3kh2j/AGR60M6Kcm1Yv6Chu7yS9kAMMXC7h+Zq1cSrPfSzqSVB2Ln9aGRbPTUhg4JOOO+KrrGVVEzgDk4rOTPRpwsky3u8x8jp2p87qqZXPNQttA+U8gVFh2VmzgDBx7GlFF1J8iuMEZZpHJOxflNV3dVKqGKoD6VZDKXZSCY92QuaryIzA5yCB90DtWj20PNk23dkCgM52j5ex9KVFQyYY/KKd93AjYdeKQgbj6jpg1myGLJ1yOnrUJbexxkYqRs52nAwKgLZwcUiWx4YjOGpQ2zhsknpgc1Cp75wB2PepI7l7eVJomaOVTlWB5BoJubLPbahYWSNf/ZHtozGY5I3ZTyTvUr3OefpWdr16lzfgxNI6JEkXmSDDyFRjcR71oQ3n2HTLLztcv7bzI96wRQhgi5POc9Kq+IrQMJrtdRlvZYkiZzLHtLRv9xlI6jtVMz5rM+p3uEUn5ske1QPclmO0L9KzGl3YBkgT6tk0IqSYH25FP8AucV69jwzxL4pztd+Nb0k58srEPwFcwnHGOOma1/Ge6Pxfqu5w5W4YBh0PvWSuMZ7159b4mexQ+FEqvtB2rhvXrmo1kZm2ktxkcHgf40PJtwF+8f0qxAq7QQOaxWmrOpSvoiH7MnfJ9Sc05bONjkqNtXMr7c044OBvHpilc1S7mcYDGT5bsMcg5qxFfSQAfaFFwg5I6H86muBzuyPTFU3PJJ6elLmsW1Z3QtxdxTDEYC/7J4NZM6bZDu4br8v8xVudFY/N3qk8u0MrDcOgPdacX2InUb+I1tKvzLugmYeavGT3HY0twhGQ3TrXOJ8lz5qH5gRz6j0rqC2+1WT1H41pYuFTniUNNO2NlPJRyvStCBSUdioHcH3qjaDa05HI8znFaloo8pvmIz2oCCva5nXLMSFBOAQaYx/ejIp94f9KweRgZxUcp+fg4yKTRzylqWWb5eg9cZpCeKiTH/66cTnipaIcieN/wCVShsdaqg4HtTs0couYtbvlqJ34AqMNkccUEgCiwcw8t+lKGHpk1EDmlDbQcGnyhzEofAJ/Smhu2Tj1qLdknmjPGO9Kwcw9z2zkVEW4ApWPGd3NRMfXJNNRE5Cscg+lRk4NB9DTdwHt9afKLmEY4zUTH1qQjjqKY3A45NFhXI2O48U18fjSsOMnvUZBC5xj3qrCAAAcfePUVKu5UJGOeBzioC+elTwptzJL2Hy/WmJMmBMAO75nAyx9Ku6QMzG5uRy4wAey1mwr9plIc5TOT7+1bsb/LkDA6VEjsob3Jnw8yt0CiosfISD35zTYWAOR8pJ/OnO2QPU1ny3PQVQg3YPPNTQkiM7uTxgntUWOefzq1bxqwIJ47HuKuKaMZy5tGRR9Buw3OAcYp9wuMsOWIwcdqmeMgAj5QOxpC53L1Ix1JqtOpMoXWhkMG3Nlfp7VAW2kN/+uta6jG8FgQBwcdKypoyHPB/wqXE5ZJoJJdzdMetV3bIIGOKJMK2AM/zqB3yxHQ1NjNuwplwT6UwyZGDUUrYbGBUUj9eaaRnzHU2MsaaVa/2w+neWVJtVuYneQJnvs/hznANZuu397FJdWl39nJnMchlhHDxgfIF9EA6D86gXVLCW0t4tUtLiWS3Ty45beYIWTJO1gR2z1FVfEMskt9GZoo4UNvGYIkbcEi2/KM+vrVGfU+nZbu1tpVhlk/fsNyxIpZseuBUsepWm9VmE8OflBliKqT9elJqCS6XeXGpRWz3lvOirKkABlQrwCPUe1aG1ntQ6xsN6ZCSD1HRh/OvWueQeIfE6zW18Y3jLyk6rMpB4OR2rlw/7sZP1Fei+PfDd1b+HLO7mZZZ7YskpiB2qjNkfgP615uCGTngiuKvH3j08PU90UHe2Tj8auRyIFAAZgPwrPVh2I/GpULsAV4+tc0kdMJGit0QNoiTsaDdPkHagP0qskTsoyxqdLZguQP8A69RdI2TbBrtirAovPaoHdGXHzD27VPJCVXOwc+lV5IyAcg1Ldy+Z20K75I4IIqlcoOc8H0q5KAD396qz84y3SnEzl5maoKTxr/DuFdWAqwBTgA9a5eYEMCecEHite6vo47beTk44Hr7Vuot6hSqKMWmS2QA+0E8DzDznrUhnaOQY7HNZ1pO0cSggFjyRjnJouLn5tq8uOp9PajkbCVdJe6ywk3n3UrY7gZp0pT7SoJJwMkCqcdylrBuk453Hjk0QXJkmMrjbu5C+g96TRjzpmkwGcjI9M00ZBOeaZ56HuM/X+VSxlNuSy8+9VyibTF5NO5wBSF19RxTyRjqPejlFcMA4FJjOc0jSAdTTRLQkHMOOKb70O4xTfMG3kinyi5hx4oBBzxULSgd6jeYcnNHKHMSlqYWqIy5IOaCwxmiwuYkJz0pOg75pgcChnIGe9Kw7jiRtqNnA4IJ9KY0nrUbSe9Fg5iRCu8BjxRdyrM4WMYVRyarvJlRk544pyAKpdz06Ad6YlLoCoNwycd6sbt/VSRjH096g3Hbz168CpY8Y4NQ3Y0ii7ahVTgDjvirCnPO5qgiYHA79TUgOc4I6dqz1OmLLEeWBJHfrTFcMTmjzcR7Rx61Ep5PZT2xVGvP2LartKnj8Ksn5cYPU8kVVgyWAz7VcIULknnoatFpltAkkZOOeh4qsYiSAQSoPGKkjfa3GM460rkLkqc5FDQ4z6FGWPk4PQ/NVKRDhgQee+K1ZCWAORgevaqkqEjAbjrilYmVmYlxk8E8VTdeCygk569q2J4cA7Rweoqk8ZUEA8HqKS8zklTfQypjgse361HC0Juo/tZlFv/H5WN+PbPFWbqLacgkVUS1e4uIoITGryNtXzHCrn3J6UjJxaL7nw70L6z+UdUdfvoL2/jeyEqwRwRwr5uNx2jGTirs/hfU42aOVrBXU4ZWvEBB9+ayb2zksrkwXDRFwA2YpBIvPuO9NJsxkz630m7hvrVha3DJPETE2QQ6kdCVPepp01KKFiur7cfxSRLj8awFu30q1bVDY3EkFy6PcXk7qr7TwG2DsKfqniPwrDL5t9e29xMi4AQGTj0x0r1JWW55Si3sH26Gdbiz1Jnu5Nvlv5blkdWHUADH+FeP+JtCuNHvXwkhsmJ8mdlxn2PoRXo138T9MiXZp2nXMuPulsRr+Vcr4r8YX3iLTjZNaw20BYM20lmOOnJrCpUp2tc66NKqne2hxQ2oMsR7VPFdCMDcQo6cmlFoMYIzzU32JCoJSuCUkz0owcSS3uI2IXzFx71qQEMP9ntWUlkg4xg1btkeN8Fjnt3qLo2SZdkRSDtHNUbiMgHirsTOoOcZ/nTZZVdcHAPSs2y0YNx0znnpis6fgmte5HUcZrHnzu+brVRMqjK5+Y4I4PFdJ4S8Bf2jaW+p6ve3r27ZKxxLtXAOOtYUC7pBmvZ/hhcST+E7a1iiaRkkdQQOAM16WHSe55WIk+hBpngHw2ygpFdyHvvuGJP1rYPgPw55YQaVbgdsZ/nmuhj8PXPmCSNo4T3BrTtLAxti7mdj6LwK6bLocrm+55fefCzSbifdawyo/ZRKePoKgtPg/I8uZZbmOP/aKj+XNe224igAESKB2NTl95zkVLiuwe1kefaP8LfDdqo+2Wi3T9xISc11Efg7wz5HlRaFp6jufJBP51pyBeTnGKdFKEHHXtSt2Jc5PqcpqHwv8L3TMTpiQnpmFih/DBrltU+C9i4J0zVL619pCJB+vNetrJyd3J6Uud3epcU9xqrKOzPnDWPhD4ntnP2G+tb4eh/dNj8a5+fwN40tCfM0iWTHUo6t/WvrAKCvT65pmxSDhRS9mmafWZHyLc6L4nt4yZtCvgB1ITOPyrHlfUUfZLazxv/daNgf5V9nPbqRyMk9qrTadDNnfEhx0JFL2SKWJZ8bM13n51ZfqDSK02fvD86+upvD9vI25UKn2qq/h0oSyGJv+ukSt/Sn7JB9ZPlVVl9j+NO3kY3MB9WFfU39nTRja1nauv+ygH8xVW40ixlB+1aNC+f8Apkho9iiliGfMZlGfvp/30Kje4IzzX0HqHgvwrdhhP4djU+qRFT+lc3c/DLwwWLQafeIc/d3sFpex7DWIPGzMSc4b8qTc7cAGvY3+HPhhY/n02+Q92S5Y/pRZfDvwsJwRHeFh/A9y2KPYsft0eQKrHqpyKlWJgdzj6V9ER+AfDUtsI20mBVI+8pO7881jX/wm0aUH7PPeQE9Asu7H5ik6LCOIj1PE1Hr+NOyo5zx2r0G/+D+oxSFrHVEmXrtnXafzFYmo/DrW7VV2GKQ/xHcQB+lZOhI3jiIGAtwAMHBpwuFBOD7KB3rRfwTr8alhZNMvrDKjfpmqz+HtVhG2bTb9Dn/ngW/UZqfYyNFiYsZG5ZmUk5xTfPJOM9OtQXEJtiROk0WezxOP6VHBLG/+qZXPsDR7Jl+3RqxzqSCOG7VcimDYB49SKw9soYMmVB9QcZqzDHeBcmF2GeSBmlyNGixK6myZg2eAKTzCBkDI6YFZZeZMGSKT2BU1Il7HGD5haNT13KRRymirxL7THaML8vTNRlhjI7etVv7Uszx9pjx7sBQ2o2TH/j5hzj++KVmW6sWEjZGRkn0qhNgZ6g/XrUs+oWK4P2uAe28VmS6naz3CW9qxnuJDtRIlLFj6Ck02S6sFuxZiuDkEn0qG10+51W7W10+1kuJn4CRjJrrdP8IEKsmryOB18iLr9C3+FdJBm2jSDTrXyQMKgjXBz/U1pDDyfxaHHVxkVpBXOVTwPrF0ftWuq0CxoFLBN7lQMDOOpx35NYuqanZ6PObTS9JdblQP9IvY/nx2KqemfWu88Q+F9S1vUkutb1UWUSoAtpBON7EdWK5wGNZH9maDbXjwi0v7q6U7WNwSzCt1TtpE45VXLWRXnvL+8gitru7mkgiGEjLHao+lNS1UDhAPetDycyEge1PW2wRmvOlNy3PZjSjHRFWKBeMDkdamWALnGfpV+GEbRhTn1qUxZXd6danUpbmdHBu6gCnmAYxnpV7acgADHsKXywynjr+tKzBlFYM5OKQxgHABGKt+WVJ2kjHXil8sAc8H3pWKKLHAI2kVSmO1Tkc+laUkBJyn41n3SEOVbnFJobM2RwVJzyKy52ywNXrsbenFUXGTyK1po5KrH2ow+48Ac17z8JmntvAlg6oCsjO+R15NeCykpauV++2EUe5r6S8MadHYeHNNs4dy3EVuodkPCkjPPrXqUo2PJxEjegviw+ZcH3qy375QSwxWQwmRgJNmezDo1ILoRH5mJHoK1scxp7GU5QlvanIX6FcCq9tqcZwq5yfUU+WWWU8fKvtS1ESFkQAu/Smrcpuwh+tVjCepJP1pjIqnlvwoSGaC3PoM1OkrFsgY9KykdV5H5+lPN2w4Xn6UrCNrcAfmbPsKcXHbgfWsVZXPrU0bvn52AUjgUWCxqqyYzkE08YwNx4NUFnQYIYZp/wBqHXIwaLCZcYgDrjFNJHUHA96riYuQaVWOSM/SiwEvyZI6npk0xkA+8MntSqMDJPPXNG8YIBHPPvSER+TuHIA9utRSW69No+lWlIPQ/WnAc9ifagaMqSzUgnHNVJdJhlHzRq31roGwPvY+mKgdT1HHpRcdznv7K8rP2eaWInptbiozDqEZGydZPTev+FdCUA6ik8sBcgU7juc1JNqKE+ZAkg/2GxUR1EgbZrWRQfRc10rQcZOAKhkgVlIxkZ4zTuNM5aWSylctzG/94DBojuZIV+QrMvbBwRXQyWET/eRSfpVOTS48nYNv04oKTRnhYNQG0ldw7OOfyqC48OxIVmtbWF3Xqu0Bvw9at3Gkhvukgjv0I/GiGTULNhhhcRg/dk+9+BphfsPKWttG3n2akMcjagODjnIqG2sdNnnzbWyRyHn5UA/TvV+OXTr+4U3j3MB7xMdqE/UVm3VuLC/MUT77c/vEIOflzyM+1Q4oE2XZdPaA7ltbOYDnmMKasx2kcsYD2dsmeqhAR/Kp4mEkQaIBwB8oZs/hmpI7hVbDqyE9mH9alqwXMW68KaRdcyabaE9eYlxWTdfDvw9MCW0q1z6iMV3YQTLlDj1AqNoZEPBOB2xxUstSZ5dc/C/QyT5VhAv/AAAVFpvguy0W8M0NvCrlcKVjAI/GvUnTepymCB26Vg6xJHCY2dlRCDyxwD+NEdynK6MUWuABgfl0p6RQWwnuHQMYY2YdsHGOPfmqF94jsYCVjdp36BYxkZ+tP0d9bvbiOQ6bb29mXB3TSHp2yMc1pczKI8B6NuEk005JAJWSPLH8e9Wb6Ozspd20IqIsaGT720DAJNT3GmeKJ/Ot9T1WyNvICFe3U7oj2YE9R6io38O28N7FNf7tRnjhjTc7/uyQME7f8aI7hJuxyZt+RwKmWIBQCMd/rTvOVlyoHHXNItwA49Tx+FeSrH0V2SImMYIbj0qIj5jwc0faELH5uKgmdmA+YADvTBXJQBg5P4UEhTuB5B6VXE2AwbBz602R8MFDDnnmkCRbZlxyfvVHkZUr24GagWZNozg49aJJkwSevWgLtMmcAAnOayL0EOcdKtS3QAJ7dhWTdzfN1xz09aVrjvbVlC6AJzzVBl/ecVamk6nNQLgZdj8o5NdFGFmcNaZv+B9G/t3xhp9jIGNvADczY746CvotvLt0EcWAR0A7V5X8GLE2theao6/6TdtsQn+FB3r0yGPf8xJLHua9GKsjyajuxrwiXlufao2tgB8oq+EGBSMo2HuQOlMgyzGUOR1HOa0bS6DxgdG6YqIqCBkDmoQ3lyBsDI9KANHLydqabcnliKI7sMvygk/Sgl3bjgUgGmFQeScim741yAeak8gnJd6Xy0UD7tAEJlY8KOaQrKfXB/SrBdRUbyMTgCgCNYWXljipUdEUAnpTDFI/rSradN55oAnW9QDgZFK14zgBQB3zUJijTrSGWNc4oAso7Ocg5qeNsdWGayzcuwO0GkDSseox9aAsa5uETHOc+lIbsEYBx9KykGActTxMiZpBY01lJOefrUu9dpIOW9qxvthzgDik86V++PpRYVjUd1xye1M83kBBVFDj77c/WpRdRoMZFAy6V3clhTXUdVGKpi9UDAFKbgv0OKLAWCAOc9aa6jHWo1I7mnrIik5P60Ahnl7sH1qKS3Hf5jUzTruxkUnm7s9KYFN7VCOVpYbCIujKoDodykdvWrWMnOeKtwKMjkdaQzJmUWzboFCgn5lxwTU9tdwyDEgxngqefyo1RFFyiRuoZiWZM8kH0FZ5ieOTkEj1xTGaKxrG+6BmT8eMfSri3O6L94MPnANZ9rKCQrcHsT3qe7nhtrcy3LRxoDyzHAP07k1DQh27ELeYwUKSzsfT1/KvMZrG68a6rcXfneTpkb+XFnsB6D1OMmuh1rU5tYtmsrKOS3tJDia4lG0sv91R15p9vLDaWsdtaIREg2qQOtJIpEukaBpejhTDCrTD/lrJ8zH/AArQluFyApyScAVkNLLJkEYHtUlsCJ0Z2IGcZ9M8ZrSwrFyaWP7ryoHHbBx+fSs+5d95TaQRwc1eWPZcxsxYMqhfKCZJHoOxB9ar3W0yhVxlVCkjpkU0Gx5QhIyc07e2Cc80UV4iPpiIMSeTTAx3EZNFFACSMcjmmb2c/MaKKGMiclZODTJpXx1oooQmV5Xbaeay7uVwp5ooraklzHJVbKSMWIyalVfPv7S0ckQyuA23g4zRRXXA4qh9K6Jaw2drDb28YSKNQqj0Fay0UV1nnscSQOKQckg0UVIgKA8kVFJGu08UUVQ0FqAJOPSrz/LwKKKzKICxPWmYyeaKKYmTRRqWwRxVoRIDnbRRQIr3EjKMDAANVi7MOTRRTQhiruPJNOEagA4yT60UUxgwC428VWeRiOtFFIBiksQCTg1NFGuBnn60UUxgxwDjtULytjrRRSGiIsxJBY0mOcdqKKoQFyoGKDcSDgHFFFIZG13N/e74pPtErHBbNFFAx3nMKel1LnqKKKQC/bZgOoP4VPBezENkjiiigQt0sV8y/a4Y5ChwrYIK/Qjmq8lukROxpRjp+9Y/1oooGVZJ5lJCyuBnHXP86iO64ZZZ3aSQLgMxztHt6UUUxrYcsCcuQS3qTmpNihcAcYzRRQQwwG5PahlBwaKKYhvmPym9tuDxnioQxz7ZoooA/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13649=[""].join("\n");
var outline_f13_21_13649=null;
var title_f13_21_13650="Vitamin A and vitamin D (topical): Drug information";
var content_f13_21_13650=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Vitamin A and vitamin D (topical): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?40/17/41235?source=see_link\">",
"    see \"Vitamin A and vitamin D (topical): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F14332638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      A+D&reg; Original [OTC];",
"     </li>",
"     <li>",
"      Baza&reg; Clear [OTC];",
"     </li>",
"     <li>",
"      Sween Cream&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F14332641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Topical Skin Product",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F14332657\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Skin protectant:",
"     </b>",
"     Topical: Apply to affected areas as needed.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F14332656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Diaper rash:",
"     </b>",
"     Topical: Apply with each diaper change and any time prolonged exposure to wet diapers may occur (ie, at bedtime).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Skin protectant:",
"     </b>",
"     Topical: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F14332658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F14332668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sween Cream&reg;:  (57 g, 142 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical [original formula]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sween Cream&reg;:  (2 g, 14 g, 85 g, 184 g, 339 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, topical:  (5 g, 60 g, 120 g, 454 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     A+D&reg; Original:  (42.5 g); (120 g);  (454 g) [in lanolin-petrolatum base]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Baza&reg; Clear:  (50 g, 142 g, 227 g) [in petrolatum base]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F14332640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Ointment",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F14693356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For external use only; avoid contact with eyes. Do not use on animal bites, severe burns, deep or puncture wounds,  or lacerations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diaper rash: Clean area and allow to dry thoroughly prior to application.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F14332645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Temporary relief of discomfort due to chapped skin or lips, cuts and scrapes, diaper rash, or minor burns",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F14332650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined: Local: Irritation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F14332646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F14332647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: For external use only; avoid contact with eyes. Do not use on animal bites, severe burns, deep or puncture wounds, or lacerations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Self-medication (OTC use): Stop use and consult healthcare provider if condition worsens, symptoms last &gt;7 days, or if symptoms resolve and then recur within a few days.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F14975293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F14975291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 86041 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-124.240.187.80-339106477A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13650=[""].join("\n");
var outline_f13_21_13650=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332638\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332641\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332657\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332656\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332658\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332668\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332640\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14693356\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332645\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332650\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332646\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332647\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14975293\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14975291\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/86041\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/86041|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/23/371?source=related_link\">",
"      Vitamin A and vitamin D (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?18/56/19331?source=related_link\">",
"      Vitamin A and vitamin D (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?40/17/41235?source=related_link\">",
"      Vitamin A and vitamin D (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_21_13651="Poly-L-lactic acid: Drug information";
var content_f13_21_13651=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Poly-L-lactic acid: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F211254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sculptra&reg;;",
"     </li>",
"     <li>",
"      Sculptra&reg; Aesthetic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F211264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Cosmetic Agent, Implant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F211255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Facial wrinkles",
"     </b>",
"     (Sculptra&reg; Aesthetic): Intradermal: 0.1-0.2 mL per individual injection to a maximum of 2.5 mL per nasolabial fold as a single treatment; may repeat treatment at &ge;3 week intervals up to 4 times",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Lipoatrophy",
"     </b>",
"     (Sculptra&reg;): Intradermal or SubQ: ~0.05-0.2 mL per individual injection depending on technique used; ~20 injections may be needed per cheek. Treatment should be individualized. Separate treatments by &ge;2 weeks. Typical course involves 3-6 treatments. Supplemental injections may be needed. Do not overfill contour deficiency. For patients with severe facial fat loss, the average treatment requires ~1 vial per cheek area per treatment.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3062216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F211240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, powder for suspension:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Sculptra&reg;, Sculptra&reg; Aesthetic: Poly-L-lactic acid USP",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F211232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F211242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sculptra&reg;: For injection into deep dermis or subcutaneous layer using tunneling, threading, or depot technique. For injection into deep dermis or subcutaneous layer. Avoid intravenous injection. Administer using 26 gauge needle; do not bend needle. Massage treatment area periodically during session to evenly distribute.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sculptra&reg; Aesthetic: For injection into the deep dermis using a tunneling/threading technique. Avoid intravenous injection. Space injections 0.5-1 cm apart. Administer using 26 gauge or larger needle; do not bend needle. Occasionally agitate syringe during session to maintain a uniform suspension. Eliminate air prior to initial injection. Stretch skin prior to inserting needle. Massage treatment area in a circular motion after every 3-4 injections and for &ge;2 minutes at then end of the treatment session to evenly distribute. Do not fully correct or overcorrect. Local or topical anesthetic may be used prior to injecting.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F211241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Restoration and/or correction of facial lipoatrophy in patients with HIV; correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles in immunocompetent patients",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F211262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Bruising (1% to 65%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Hematoma (up to 28%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site: Edema (3% to 81%), tenderness (81%), redness (78%), pain (71%), papules (3% to 52%), bleeding (34%), pruritus (20%), nodules (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Discomfort (up to 19%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever (&lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: erythema (up to 10%), injection site reactions (&lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing/case reports: Allergic reaction, angioedema, brittle nails, colitis, ectropion, fatigue, hair breakage, hypersensitivity  reaction, hypertrophy, joint aches, malaise, periorbital nodules, photosensitivity, rash, scar/skin discoloration, skin infection, skin roughness, skin sarcoidosis, telangiectasia, urticaria, visible nodules",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Injection site reactions: Abscess, atrophy, discharge, fat atrophy, granuloma, induration",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F211245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to poly-L-lactic acid or any component of the formulation; history or susceptibility to hypertrophic scarring or keloid formation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F211234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Injection site reactions: Injection site reactions including, bleeding, bruising, edema, erythema, and inflammation, have occurred within days to months after injection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity: Patients should be instructed to limit exposure to excessive sunlight or UV lamps until any swelling or redness is resolved.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticoagulants/antiplatelets: Use with caution in patients on anticoagulants or antiplatelet medications.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Non-Caucasians: Safety and efficacy in non-Caucasians are limited.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Women: Safety and efficacy are limited in women with HIV.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Administration: Avoid I.V. injection; may lead to occlusion, infarction, or embolism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Not for use if skin inflammation or infection exists in or near the treatment area; control inflammation or infection before use. Avoid use with implants. Avoid overcorrection of contour deficit; improvement occurs over weeks of treatment. Safety and efficacy have not been established for use in the lips or periorbital area. Sculptra&reg; Aesthetic has not been evaluated in immunocompromised patients.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6222419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F211247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safety for use during pregnancy has not been established.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F211248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safety for use during breast-feeding has not been established. HIV-infected mothers are discouraged from breast-feeding to decrease potential transmission of HIV.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F211233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Poly-L-lactic acid is an immunologically inert synthetic polymer. It increases dermal thickness by causing a local reaction leading to an increase in collagen deposits. It is eventually degraded and undergoes resorption.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F211244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Onset of action: Weeks to months for full effect of treatment",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Moyle GJ, Lysakova L, Brown S, et al, &ldquo;A Randomized Open-Label Study of Immediate Versus Delayed Polylactic Acid Injections for the Cosmetic Management of Facial Lipoatrophy in Persons With HIV Infection,&rdquo;",
"      <i>",
"       HIV Med",
"      </i>",
"      , 2004, 5(2):82-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/21/13651/abstract-text/15012646/pubmed\" id=\"15012646\" target=\"_blank\">",
"        15012646",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Valantin MA, Aubron-Olivier C, Ghosn J, et al, Polylactic Acid Implants (New-Fill) to Correct Facial Lipoatrophy in HIV-Infected Patients: Results of the Open-Label Study VEGA,&rdquo;",
"      <i>",
"       AIDS",
"      </i>",
"      , 2003, 17(17):2471-7.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10301 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.122.249.114-555B9DE994-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13651=[""].join("\n");
var outline_f13_21_13651=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211254\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211264\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211255\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3062216\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211240\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211232\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211242\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211241\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211262\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211245\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211234\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299902\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6222419\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211247\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211248\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211233\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211244\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10301\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10301|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_21_13652="Chest x-ray pulmonary atresia with intact VS";
var content_f13_21_13652=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F88537&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F88537&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 610px\">",
"   <div class=\"ttl\">",
"    Chest radiograph of an infant with pulmonary atresia with intact ventricular septum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 590px; height: 512px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anteroposterior (AP) chest radiograph of a cyanotic neonate with pulmonary atresia with an intact ventricular septum, demonstrating right atrial enlargement and cardiomegaly due to significant tricuspid regurgitation. There is also a relative paucity of pulmonary vascularity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13652=[""].join("\n");
var outline_f13_21_13652=null;
var title_f13_21_13653="Collateral circulation SVC syndrome";
var content_f13_21_13653=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F75771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F75771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Collateral circulation from superior vena cava syndrome falsely suggests a liver \"hot spot\".",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 546px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Contrast-enhanced axial CT image shows a dilated internal mammary (IM) vein (red arrow) connecting to the portal and hepatic venous circulation to eventually drain into the inferior vena cava (IVC). This process appears to form an enhancing liver \"hot spot\" that is actually draining venous blood from the obstructed SVC. Note also the dilated azygos and hemiazygos veins (white arrowheads) that connect to the ascending lumbar veins and IVC. Bottom panel: Axial image at the level of the liver shows segmental enhancement of parts of the right and left lobes due to collateral flow from the IM vein.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13653=[""].join("\n");
var outline_f13_21_13653=null;
var title_f13_21_13654="Progressive doppler abnormality";
var content_f13_21_13654=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    These panels show progressive Doppler abnormality in the ductus venosus, inferior vena cava, and umbilical vein",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 496px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With increasing Doppler abnormality forward flow during atrial systole decreases in both precordial veins. In the ductus venosus forward flow may completely cease, or even reverse. In the umbilical vein the associated increase in central venous pressure is reflected in progression from monophasic to bi- and tri-phasic pulsations.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13654=[""].join("\n");
var outline_f13_21_13654=null;
var title_f13_21_13655="Magnetic source imaging";
var content_f13_21_13655=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F76925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F76925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 579px\">",
"   <div class=\"ttl\">",
"    Magnetic source imaging (MSI)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 559px; height: 535px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Magnetic source imaging (MSI) showing the right anterior frontal location of the dipoles calculated from the right frontal spike discharges from the case in figure 1 (red). Blue dots indicate the posterior frontal/central location of dipoles calculated from right-sided slow waves in the same patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13655=[""].join("\n");
var outline_f13_21_13655=null;
var title_f13_21_13656="Skin biopsy morphea";
var content_f13_21_13656=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F73941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F73941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Stages of morphea on skin biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 232px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: Skin biopsy from an early stage of morphea showing a mononuclear infiltrate in the interstitium and hyalinization and widening of occasional collagen bundles. Right panel: Burnt out stage of morphea. The dermal collagen bundles are widened with loss of their fibrillar architecture. There is only a sparse plasma cell rich infiltrate in the interstitium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Magro, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13656=[""].join("\n");
var outline_f13_21_13656=null;
var title_f13_21_13657="Breast milk expression for the preterm infant";
var content_f13_21_13657=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Breast milk expression for the preterm infant",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/21/13657/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13657/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13657/contributors\">",
"     Nancy M Hurst, PhD, RN, IBCLC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/21/13657/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13657/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/21/13657/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13657/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/21/13657/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human milk is recognized as the optimal feeding for all infants because of its proven health benefits to infants and their mothers. The World Health organization (WHO), the American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), and the United States Preventive Services Task Force all recommend breastfeeding for the first six months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link\">",
"     \"Infant benefits of breastfeeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1461?source=see_link\">",
"     \"Maternal and economic benefits of breastfeeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, mothers of vulnerable infants, such as preterm infants, encounter a variety of unique breastfeeding barriers and challenges that result in a decreased rate of breastfeeding in preterm compared to term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. As an example, in Massachusetts, breastfeeding initiation rates were 77, 70, and 63 percent in term infants, infants born between 32 and 36 weeks gestation, and those born between 24 and 31 weeks, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/5\">",
"     5",
"    </a>",
"    ]. For extremely premature infants, a major barrier is their inability to breastfeed effectively for some time after delivery, which requires their mothers to establish and maintain milk production by milk expression either by hand or by use of a pump. As a result, efforts need to be made to support both breast milk expression and breastfeeding for the maternal-preterm infant dyad, because the benefits of human milk are well-established in these infants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link&amp;anchor=H2#H2\">",
"     \"Human milk feeding and fortification of human milk for premature infants\", section on 'Advantages of human milk'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Breast milk expression for the premature infant will be reviewed here. Breastfeeding the premature infant, the nutritional composition and fortification of human milk, and approach to enteral feeds in the preterm infant are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/12/36040?source=see_link\">",
"     \"Breastfeeding the preterm infant\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/28/458?source=see_link\">",
"     \"Nutritional composition of human milk and preterm formula for the premature infant\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link\">",
"     \"Human milk feeding and fortification of human milk for premature infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/8/19593?source=see_link\">",
"     \"Approach to enteral nutrition in the premature infant\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PARENTAL SUPPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is strong evidence that a combination of prenatal and postnatal educational and support interventions improve breastfeeding rates for all new parents, which is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42616?source=see_link\">",
"     \"Breastfeeding: Parental education and support\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the neonatal intensive care unit (NICU), educational efforts are needed to address the specific breastfeeding needs of parents with preterm infants. In most cases, mothers who deliver prematurely have not made a final decision on whether to breastfeed their infant and may not have the necessary information to make an informed decision. Clinical staff should discuss the benefits of human milk, including the long-term effects of exclusive breastfeeding. In most cases, mothers opt to feed their infant breast milk and are willing to express their milk for at least one to two weeks when they learn about the benefits of human milk [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because many preterm infants cannot initially feed at the breast, mothers need instructions regarding expression and collection of milk. At the point that the infant can breastfeed, mothers require additional instructions on how best to initiate breastfeeding [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Efforts to promote breastfeeding should be directed and coordinated by a clinician with expertise in both lactation and intensive neonatal care. Staff should have a comprehensive understanding of the benefits of breastfeeding, and the policy and procedures of the lactation support service and be trained to implement the policy. Optimal care practice policy, which promotes breastfeeding, is outlined in the criteria required for World Health Organization and the United Nations Children's Fund Baby-Friendly Hospital, and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8217?source=see_link&amp;anchor=H2#H2\">",
"     \"Initiation of breastfeeding\", section on 'Hospital environment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The impact of lactational counseling was illustrated in a randomized trial of preterm infants between 26 and 37 weeks gestation (mean age 32 weeks) whose mothers intended to breastfeed [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/11\">",
"     11",
"    </a>",
"    ]. Women who received weekly peer breastfeeding counseling compared to those who received standard care were more likely to provide breast milk to their infant at 12 weeks postpartum (OR 2.8, 95% CI 1.1 to 7.1). Peer counselors help mothers learn to use the breast pump, breastfeed, and provide skin-to-skin care (also referred to as kangaroo care).",
"   </p>",
"   <p>",
"    In another study, lactational counseling led to a high rate of initiating breastfeeding (84 percent) in mothers of very low birth weight infants (birth weights below 1500 g) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/12\">",
"     12",
"    </a>",
"    ]. Counseling included education on the benefits of human milk, use and procurement of a breast pump, and storage of milk. Counseling promoting breastfeeding did not increase maternal stress and anxiety.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EFFECTS OF PREMATURITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature infants often are unable to breastfeed effectively for some time after delivery. This requires mothers to establish and maintain milk production by milk expression.",
"   </p>",
"   <p>",
"    However, mothers who deliver prematurely have difficulty in establishing an adequate milk supply [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Milk production decreases with lower gestational age, which may in part be due to incomplete mammary development because of the shortened pregnancy. This was illustrated in a study of 46 Australian mothers, which showed that milk production was lower in mothers who delivered before 28 weeks gestation compared to those who delivered between 28 and 34 weeks gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/14\">",
"     14",
"    </a>",
"    ]. Lower volumes persisted to the 10th day postpartum in women who were delivered at an earlier gestation. In addition, lactogenesis stage II (secretory activation, which is marked by the onset of copious milk production) occurred later in mothers who delivered before 28 weeks gestation, a finding which has been noted in earlier studies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6519?source=see_link&amp;anchor=H3#H3\">",
"     \"Physiology of lactation\", section on 'Pregnancy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6519?source=see_link&amp;anchor=H9#H9\">",
"     \"Physiology of lactation\", section on 'Lactogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these challenges, the majority of mothers who deliver prematurely are capable of producing enough milk to feed their offspring. It is important to identify the barriers for successful establishment of milk production, so that support and interventions can be directed towards addressing these impediments.",
"   </p>",
"   <p>",
"    The following factors are associated with a decreased likelihood that mother's milk will be used for infant feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lower gestational age, as mentioned previously",
"     </li>",
"     <li>",
"      Irregular and infrequent emptying of the breast",
"     </li>",
"     <li>",
"      Increased maternal-infant separation",
"     </li>",
"     <li>",
"      Decreased skin-to-skin contact (see",
"      <a class=\"local\" href=\"#H25\">",
"       'Skin-to-skin contact'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Maternal fatigue and stress",
"     </li>",
"     <li>",
"      Young maternal age",
"     </li>",
"     <li>",
"      Low maternal annual income (ie, less than $50,000)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon these findings, it is imperative that mothers of premature infants receive counseling to increase their milk supply, and ultimately initiate breastfeeding. Educational and supportive interventions are focused upon the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Teaching the mother how to regularly express milk and fully empty her breasts at least six times a day",
"     </li>",
"     <li>",
"      Optimizing milk production",
"     </li>",
"     <li>",
"      Teaching the mother how to properly collect and store expressed milk",
"     </li>",
"     <li>",
"      Determining when to initiate oral feeds and teach the mother proper breastfeeding techniques",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional support should be directed towards subgroups of women who are less likely to breastfeed, and counseling should focus on the specific issues of the mother that negatively impact on breastfeeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42616?source=see_link&amp;anchor=H3#H3\">",
"     \"Breastfeeding: Parental education and support\", section on 'Barriers to breastfeeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MILK EXPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mothers of premature infants may need to express their milk after delivery because of the inability of their infant to breastfeed. Milk expression is most often performed using a mechanical breast pump because of its efficiency in removing milk within a reasonable time period and its ability to thoroughly empty the breast.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Breast pump selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;For mothers who are totally dependent upon expression of their milk, a hospital grade electric breast pump with its ability to simultaneously extract milk from both breasts is recommended. Double pumping reduces the total time required for milk extraction and generally takes about 10 to 15 minutes after let-down has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/16\">",
"     16",
"    </a>",
"    ]. Simultaneous pumping also appears to increase the total volume of extracted milk during a single pumping session [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, these pumps have stronger motors and are more durable so that they are less likely to fail during intensive use than less expensive models.",
"   </p>",
"   <p>",
"    A hospital grade double pump may be rented through hospitals, pharmacies, lactation consultants, and home health agencies. For women in the United States who are participants of the Supplemental Nutrition Program for Women, Infants, and Children (WIC), these pumps are available at no charge in most states.",
"   </p>",
"   <p>",
"    Selection of the correct size breast shield is important, as too small an opening may impede milk flow. The opening of the shield should be slightly wider than the nipple to ensure good milk flow and reduce the potential for nipple irritation.",
"   </p>",
"   <p>",
"    For mothers who cannot afford or prefer not to obtain an electric pump, one manual pump model has been shown to extract the same volume of milk during sequential pumping as the hospital grade electric pump, although the pumping time is longer [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Timing and frequency",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Initiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mothers who are unable to nurse should be advised to initiate milk expression within the first 24 hours after delivery (prior to the onset of lactogenesis II). Delaying milk expression beyond this point is associated with lower milk volumes on days 10 through 14 postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/19\">",
"     19",
"    </a>",
"    ]. Initiation within the first one to six hours after delivery appears to result in greater total volume [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/20\">",
"     20",
"    </a>",
"    ]. Volume suppression, however, is temporary. By four weeks postpartum, milk volume is no longer associated with the day on which pumping was initiated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among pump-dependent mothers, milk expression frequencies greater than six times per day are associated with higher milk volumes than less frequent pumping in the first six weeks after delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/21\">",
"     21",
"    </a>",
"    ]. Some mothers, however, require greater pumping frequencies to establish and maintain adequate milk production to meet the needs of their infant. Therefore, we recommend at least eight sessions of pumping per 24 hours with complete breast emptying every time. The optimal number of daily milk expressions will vary with each mother, and hospital staff should monitor milk production closely and make adjustments in the pumping schedule as needed. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Inter-pumping intervals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Between pumping, milk stasis occurs, and the response of mothers to milk stasis during interpumping intervals varies. Some mothers may experience a reduction in milk synthesis when non-pumping intervals extend beyond six hours, while others maintain the same milk production rate regardless of the length of the inter-pumping interval.",
"   </p>",
"   <p>",
"    When milk volume is inadequate, characterizing the maternal response to milk stasis during inter-pumping intervals may be helpful in developing effective strategies for increased milk production. The following is one approach that determines milk production rates between feeds and over a 24-hour period, and uses this information to adjust the pumping schedule, as needed [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Determine the overall rate of milk synthesis over a 24-hour period: calculated as the measured 24-hour",
"      <span class=\"nowrap\">",
"       volume/1440",
"      </span>",
"      minutes.",
"     </li>",
"     <li>",
"      Determine and compare the rates of milk synthesis for inter-pumping intervals of long and short duration.",
"     </li>",
"     <li>",
"      Compare the rates of long inter-pumping intervals (six hours or greater) to the 24 hour synthesis rate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mothers who are relatively less responsive to milk stasis will have similar synthesis rates during short and long inter-pumping intervals and can safely include longer inter-pumping intervals at night. In contrast, mothers whose milk production decreases with increasing prolongation of the inter-pumping intervals need to insure that their breasts are emptied on a frequent and regular basis to prevent down regulation of production.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;To help with monitoring milk expression and volume, we have found it useful to have mothers maintain pumping records that document the frequency and volume of milk expression in the first few weeks post delivery. These records reflect volume patterns following different lengths of inter-pumping intervals, which are used to adjust pumping frequency and optimize volume production.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Milk volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;The single most important factor predicting breastfeeding success is the ability of the mother to produce enough milk to meet the requirements of her infant at discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/7,24,25\">",
"     7,24,25",
"    </a>",
"    ]. By the time of discharge, most preterm infants require about 500 mL of milk per day. Mothers of premature infants who produce less than 350 mL of milk per day by days 10 to 14 postpartum are at risk of producing insufficient milk to feed their infants at discharge. Efforts to increase production should be initiated at that time and continue during the infant's hospitalization. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Optimizing milk production'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The full feeding volume for extremely preterm infants generally is considered to be about 150",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per day. This volume will usually be supplemented with fortifiers that provide additional macro and micronutrients. However, volumes up to 200",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per day are well tolerated by most human milk-fed premature infants who do not have significant chronic cardiopulmonary diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/26\">",
"     26",
"    </a>",
"    ]. These volumes may be needed for larger preterm infants or infants who are preparing for hospital discharge that will be fed exclusively human milk after discharge. Increased tolerance of preterm infants to higher feeding volumes with human milk compared to formula has been attributed to a faster gastric emptying rate with human milk versus formula. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link\">",
"     \"Human milk feeding and fortification of human milk for premature infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one observational study of mothers with preterm infants (birth weight &lt;1500 g and gestational age &lt;31 weeks), instruction and support of a combination of mechanical breast pumping and manual expression of breast milk resulted in a high and sustainable daily milk production for most mothers through the entire eight week study period [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/27\">",
"     27",
"    </a>",
"    ]. Mothers were instructed to begin pumping within six hours after delivery, and milk volume was assessed on a weekly basis. Mean daily milk volume (MDMV) was about 320 mL at one week postpartum and steadily increased to 820 mL by the end of study. Of the 42 mothers who completed the study, 75 percent had MDMV &gt;500 mL. The following factors were associated with increased milk production:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased frequency of hand expression of colostrum during the first three postpartum days correlated with larger MDMV from week 1 through week 7.",
"     </li>",
"     <li>",
"      Frequent pumping (at least seven times a day) compared to less frequent pumping was associated with a higher MDMV at week 2 post-partum (622 versus 402 mL) and a higher but not statistically significant MDMV at week 8 (1019 versus 752 mL).",
"     </li>",
"     <li>",
"      In 39 of 42 mothers, MDMV increased from 583 &plusmn;383 to 863 &plusmn; 506 mL after they participated in an instructional post-discharge mechanical and hand pumping session that monitored milk production given at a mean 20.6 &plusmn;9.6 days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results demonstrate that mothers of preterm infants can produce sufficient amounts of breast milk for the nutritional needs of their infants using a combination of mechanical and hand pumping.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hindmilk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fat content of expressed milk increases from the beginning to the end of an expression session. The final drops of milk (hindmilk) have the highest fat and caloric content, and contribute disproportionately to the infant's calorie intake [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Mothers should be encouraged to pump until milk ceases to flow, which generally takes about 10 to 15 minutes, but this may vary from woman to woman. Once lactation is established, some mothers may find that less time is required to achieve satisfactory breast emptying. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/28/458?source=see_link&amp;anchor=H11#H11\">",
"     \"Nutritional composition of human milk and preterm formula for the premature infant\", section on 'Lipid in human milk'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Breast massage during the final minutes of pumping can increase breast emptying and assist in extraction of higher fat hindmilk. This technique also allows the mother to locate and drain alveoli containing residual milk, thereby reducing the potential for developing plugged ducts and mastitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"     \"Common problems of breastfeeding and weaning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The caloric content can be manipulated by preferential feeding of hind milk by collecting the hindmilk separately. There are some observational data that suggest this technique accelerates infant growth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/30\">",
"     30",
"    </a>",
"    ], but this has not been confirmed in randomized controlled trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     MILK COLLECTION AND STORAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Improper collection, storage, and preparation of expressed human milk for feeding can negatively impact the antimicrobial and nutrient properties of human milk. As a result, it is important that hospitals have policies and procedures to ensure optimal handling of expressed milk, as discussed in the following sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Milk collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although no mother's milk is sterile [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/31,32\">",
"     31,32",
"    </a>",
"    ], the mother should learn the following collection technique to reduce further bacterial growth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/33\">",
"     33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Wash hands prior to each milk expression.",
"     </li>",
"     <li>",
"      Disassemble all pump parts, and use a bottle brush in small crevices.",
"     </li>",
"     <li>",
"      Wash all milk collection equipment that comes in contact with the milk with hot soapy water, and rinse thoroughly following each use.",
"     </li>",
"     <li>",
"      Sterilize milk collection equipment once daily either by using a microwave sterilizing bag or by boiling it in water for 15 to 20 minutes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Transport containers (coolers or ice chest) should be thoroughly cleaned inside and outside. Individuals transporting milk should wash their hands before picking up and delivering the milk to prevent inadvertent contamination of milk containers. This is particular important when the family has pets or family members work in contaminated environments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Milk storage",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Containers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glass (Pyrex) and hard plastic (polypropylene) containers are recommended for human milk storage because they provide stability for water-soluble constituents and are easy to handle [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Hard plastic containers scratch and are difficult to clean over time, at which point they should be replaced. Flexible, polyethylene bags are not recommended for milk collection and storage due to the significant greater loss of cells, and chance of leakage during storage and handling [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition transparent plastic containers or bottles that contain bisphenol A should be avoided because exposure to bisphenol A may be associated with impairment of infant development [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/36\">",
"     36",
"    </a>",
"    ]. These containers often are marked with the recycling number 7 or the letters PC, which stand for \"polycarbonate\" plastic.",
"   </p>",
"   <p>",
"    Each container should be labeled with the infant's name, medical record number, date and time of collection, and use of any maternal medications. Mothers should be provided with labels for this purpose and instructed to use",
"    <span class=\"nowrap\">",
"     pens/markers",
"    </span>",
"    that will not smudge or wash off when exposed to water. If the milk is to be transferred to another container by the nurse or other designated staff prior to feeding, each individual",
"    <span class=\"nowrap\">",
"     syringe/bottle",
"    </span>",
"    should be labeled appropriately. Prior to feeding, the information from the labeled milk should be verified against the infant's name band. A container of unlabeled milk should never be administered to an infant under any circumstance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Temperature",
"    </span>",
"    &nbsp;&mdash;&nbsp;The temperature at which milk is stored depends upon the intended duration of storage prior to feeding. Many of the protective antimicrobial properties of human milk are temperature sensitive. Heating, freezing, thawing, and prolonged storage result in some loss of bioactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Although stored and frozen milk remain superior to formula in its protective antimicrobial and nutrient properties, milk that is fed immediately after expression offers the highest degree of natural bioactivity. As a result, it is recommended that at least one daily feed should include fresh milk (never frozen and pumped within 96 hours) whenever possible.",
"   </p>",
"   <p>",
"    The Human Milk Banking Association of North America [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/39\">",
"     39",
"    </a>",
"    ] and the American Dietetic Association [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/40\">",
"     40",
"    </a>",
"    ] provide the following temperature recommendations for the storage of expressed breast milk for hospitalized infants. Temperature depends upon the length of time from expression and when the milk will be used.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Room temperature (25 to 27&ordm;C; 77 to 79&ordm;F), used within four hours",
"     </li>",
"     <li>",
"      Refrigeration (1 to 4&ordm;C; 35 to 40&ordm;F), used between 4 and 48 hours",
"     </li>",
"     <li>",
"      Frozen (-18 to -20&ordm;C; 0 to 4&ordm;F), used between 48 hours and three months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A subsequent study demonstrated refrigeration of milk at 4&ordm;C for as long as 96 hours did not significantly change its osmolality, total bacterial colony counts, or concentrations of sIgA, lactoferrin, and fat [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/41\">",
"     41",
"    </a>",
"    ]. There was a 16 percent decrease in the white blood cell concentration and a decrease in pH from 7.21 to 6.68, however, neither change was clinically significant.",
"   </p>",
"   <p>",
"    Prolonged home storage of milk or storage outside the supervision of the hospital staff should be discouraged to reduce the possibility of inadvertent",
"    <span class=\"nowrap\">",
"     freeze/thaw",
"    </span>",
"    or contamination.",
"   </p>",
"   <p>",
"    Milk can be warmed gradually to approximately 98&ordm;F (37&ordm;C) in a warm water bath (not to exceed 20 to 30 minutes). One should avoid submerging bottles in water when using the warm water bath method. Rapid heating or microwaving adversely affects the breast milk's immunologic and nutritional properties [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/37,42\">",
"     37,42",
"    </a>",
"    ]. If the infant is in an incubator, the feeding syringe can be placed inside the incubator for gradual warming. The bottle should be labeled with the",
"    <span class=\"nowrap\">",
"     date/time",
"    </span>",
"    when the milk was thawed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Aliquoting",
"    </span>",
"    &nbsp;&mdash;&nbsp;If milk from a single expression is divided into multiple storage containers, mothers should be advised to mix the milk thoroughly but gently before distributing it. Fat distribution in expressed milk is uneven not only because of changing lipid content as the breast is emptied, but also because milk fat (cream) rises to the top after expression. If the milk is not mixed, the infant can receive feedings with markedly different fat and caloric values, affecting metabolic processes and overall weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/30\">",
"     30",
"    </a>",
"    ]. Milk from several pumping sessions should not be combined into one container.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial routine culturing of milk is not recommended because results were not predictive of infection when evaluated prior to the occurrence of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/1,43\">",
"     1,43",
"    </a>",
"    ]. Bacterial screening with subsequent pasteurization also does not improve gastrointestinal morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OPTIMIZING MILK PRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strategies to stimulate milk synthesis should be initiated immediately if milk production is deemed inadequate or at risk. In general, more rapid increases in production can be achieved when interventions are initiated in the early postpartum period [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/19\">",
"     19",
"    </a>",
"    ]. However, milk production can be increased at any point in lactation.",
"   </p>",
"   <p>",
"    Strategies to increase milk volumes include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Identifying any risk factors associated with decreased milk production",
"     </li>",
"     <li>",
"      Frequent emptying of the breast (at least six times a day)",
"     </li>",
"     <li>",
"      Bedside pumping",
"     </li>",
"     <li>",
"      Tactile nipple stimulation",
"     </li>",
"     <li>",
"      Skin-to-skin contact",
"     </li>",
"     <li>",
"      Uninterrupted sleep of five and six hours",
"     </li>",
"     <li>",
"      Ensuring proper use of breast pump including pump size shield",
"     </li>",
"     <li>",
"      Consideration of the use of galactagogues, which should be done in conjunction with the mother's health care provider",
"     </li>",
"     <li>",
"      Reducing maternal stress and providing a relaxed and comfortable environment for pumping",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough history is important to identify factors associated with decreased milk production:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      History of breast surgery",
"     </li>",
"     <li>",
"      Endocrine disorders (eg, hypothyroidism, polycystic ovarian syndrome)",
"     </li>",
"     <li>",
"      Extended bedrest prior to delivery",
"     </li>",
"     <li>",
"      Maternal medication (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/8/20613?source=see_link\">",
"       pseudoephedrine",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/1/32794?source=see_link&amp;anchor=H3#H3\">",
"       \"Principles of medication use during lactation\", section on 'Drug effects on milk supply'",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Breast emptying",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following secretory activation, maintenance of milk production depends upon the removal of milk on a regular basis. Failure to remove milk results in excessive and prolonged accumulation of milk within the alveolar lumen leading to alveolar distension and elevation of intra-mammary pressure, which result in decreased milk production. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6519?source=see_link&amp;anchor=H8#H8\">",
"     \"Physiology of lactation\", section on 'Milk production'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To enhance milk production, emptying of the breast should be done on a regular and frequent basis at least six times a day.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pumping schedule should be individualized based upon the maternal milk production response to milk stasis during inter-pumping intervals. Pumping sessions should be observed to ensure the correct nipple shield size is used and that the breasts are completely emptied with production of hindmilk. If the milk extraction techniques are performed efficiently, increasing the frequency of breast emptying by two sessions per 24 hours results in an average milk volume increase of 80",
"      <span class=\"nowrap\">",
"       mL/per",
"      </span>",
"      day over a two week time period [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Milk expression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In mothers who are breastfeeding, preterm infants are often unable to withdraw milk from the breast effectively. As a result, during the transition from partial to exclusive breastfeeding, pumping after nursing ensures complete breast emptying. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/12/36040?source=see_link\">",
"       \"Breastfeeding the preterm infant\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Bedside pumping",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, regular and frequent pumping is critical for establishing and maintaining milk production. Bedside pumping allows clinical staff to directly detect and address any pumping difficulty, monitor the maternal pumping schedule, and emphasize to the mother the need to maintain a regular and frequent pumping schedule. It also enables physical contact between the mother and infant during milk expression that augments release of lactogenic hormones, such as oxytocin. In addition, bedside pumping decreases the mother's time away from the infant for pumping either in the mother's room or a \"pumping room\" [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Tactile nipple stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the hormonal regulation of lactogenesis and milk ejection is complex and not completely understood, nipple stimulation is associated with increases in the plasma concentration of prolactin and oxytocin. Preterm infants who have not yet developed the oral skills needed for adequate milk transfer may suckle the emptied breast after the mother has pumped. This provides tactile nipple stimulation and non-nutritive sucking, which may enhance the infant's transition from tube to oral feeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/4/21576?source=see_link&amp;anchor=H4#H4\">",
"     \"Sucking and swallowing disorders in the newborn\", section on 'Nonnutritive sucking'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/12/36040?source=see_link&amp;anchor=H5#H5\">",
"     \"Breastfeeding the preterm infant\", section on 'Nonnutritive suckling'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Skin-to-skin contact",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin-to-skin (STS) contact, also referred to as kangaroo care, increases breastfeeding rates and duration in full term and late preterm infants [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/45\">",
"     45",
"    </a>",
"    ]. An increased duration of breastfeeding was also associated with STS contact in a randomized Colombian trial of preterm infants with birth weights below 2000 g (average weight for the STS contact group was 1678 g versus 1715 g for the controls) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a small trial of low birth weight (LBW) infants (birth weight less than 2500 g), mothers who initiated STS contact during the first four weeks after delivery had a greater increase in their milk volume compared to control mothers (647 versus 530",
"    <span class=\"nowrap\">",
"     mL/24",
"    </span>",
"    hour period) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    STS contact also increases the mother-infant bonding, which promotes a sense of maternal competence and reduces maternal stress [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preterm infants, even those who are very premature (&le;28 weeks gestation) and mechanically ventilated, can be safely placed in STS contact with the mother [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/50-53\">",
"     50-53",
"    </a>",
"    ]. Physiologic stability of the infant is best maintained when the mother is positioned reclining at an angle of 45 to 60 degrees. The infants are placed prone and upright between the breasts with the head turned so that the side of the face rests against the surface of one breast. The use of reclining chairs and foot stools provide appropriate and comfortable positioning of the mother and infant. Mirrors positioned to allow mothers to observe their infant's face enhance the maternal experience. For optimal results, sessions should last for two or more hours. Fathers may also participate in STS contact.",
"   </p>",
"   <p>",
"    In a NICU that is adequately staffed with trained personnel, STS contact has no deleterious effects on heart rate, oxygen saturation, oxygen consumption, or the number of apneic or bradycardic spells in stable or ventilated LBW infants [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Galactagogues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Galactagogues (or lactagogues) are medications or other substances believed to assist initiation, maintenance, or augmentation of maternal milk production. The agents most commonly used are dopamine receptor antagonists (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/47/759?source=see_link\">",
"     metoclopramide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"     domperidone",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data regarding the use of galactagogues are limited and inconsistent.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one randomized trial of mothers of full term infants with inadequate milk production, there was no difference in the amount of milk production between mothers who received",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/47/759?source=see_link\">",
"       metoclopramide",
"      </a>",
"      at an oral dose of 10 mg every eight hours compared to mothers who received placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/56\">",
"       56",
"      </a>",
"      ]. However, there are observational data that suggest increased milk production in some mothers of preterm infants treated with metoclopramide (10 mg tablet every eight hours for seven days and then tapered) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a systematic review, two trials reported",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"       domperidone",
"      </a>",
"      increased the expressed breast milk volume in mothers with preterm infants [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In the first trial, mothers of infants born below 31 weeks gestation who were randomly selected to receive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"       domperidone",
"      </a>",
"      for 14 days had greater breast milk volumes and serum prolactin levels by day 14 compared to mothers who received placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/59\">",
"       59",
"      </a>",
"      ]. There appeared to be no significant change in the nutrient content of milk between the two groups of mothers.",
"     </li>",
"     <li>",
"      In the second trial, mothers who received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"       domperidone",
"      </a>",
"      for seven days had greater mean increase in milk production compared to mothers who received placebo (49.5 &plusmn; 29.4 versus 8 &plusmn; 39.5 mL ) and higher serum prolactin levels by day 5 [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/60\">",
"       60",
"      </a>",
"      ]. Small amounts of domperidone were detected in breast milk samples of mothers who received domperidone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although no adverse effects in the nursing infant have been reported, the American Academy of Pediatrics considers the use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/47/759?source=see_link\">",
"     metoclopramide",
"    </a>",
"    during lactation to be of concern because of the potent central nervous system effects that the drug is capable of producing [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13657/abstract/61\">",
"     61",
"    </a>",
"    ]. Similar effects are not seen with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"     domperidone",
"    </a>",
"    as it does not cross the blood-brain barrier.",
"   </p>",
"   <p>",
"    We do not routinely use a galactagogue agent and reserve its use in mothers with diminished breast milk volume who failed to increase their milk production with adequate lactation counseling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/22/36194?source=see_link\">",
"       \"Patient information: Breast pumps (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?17/25/17813?source=see_link\">",
"       \"Patient information: Breast pumps (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend human milk for preterm infants because of its proven benefits for both infants and mothers (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link\">",
"       \"Infant benefits of breastfeeding\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1461?source=see_link\">",
"       \"Maternal and economic benefits of breastfeeding\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mothers of preterm infants below 34 weeks gestation generally need to express their milk because their infant is unable to completely feed at the breast.",
"     </li>",
"     <li>",
"      Milk expression is most often performed using a mechanical breast pump because of its efficiency in removing milk within a reasonable time period and its ability to thoroughly empty the breast. Milk expression should be started within eight hours after delivery and performed at least six times a day to ensure optimal milk supply in the first weeks of life. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Milk expression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thorough breast emptying optimizes milk production and ensures expression of hindmilk, which has the highest fat and caloric content of human milk. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Optimizing milk production'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Hindmilk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Optimal handling of expressed milk reduces the bacterial growth and protects the antimicrobial and nutritional properties of human milk. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Milk collection and storage'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Judy Hopkinson, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/1\">",
"      Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129:e827.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Global Strategy for Infant and Young Child Feeding (2003). Available at: www.who.int/nutrition/publications/infantfeeding/en/index.html (Accessed on April 10, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/3\">",
"      U.S. Preventive Services Task Force. Primary care interventions to promote breastfeeding: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/4\">",
"      Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. Obstet Gynecol 2007; 109:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/5\">",
"      Merewood A, Brooks D, Bauchner H, et al. Maternal birthplace and breastfeeding initiation among term and preterm infants: a statewide assessment for Massachusetts. Pediatrics 2006; 118:e1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/6\">",
"      Donath SM, Amir LH. Effect of gestation on initiation and duration of breastfeeding. Arch Dis Child Fetal Neonatal Ed 2008; 93:F448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/7\">",
"      Meier PP. Breastfeeding in the special care nursery. Prematures and infants with medical problems. Pediatr Clin North Am 2001; 48:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/8\">",
"      Hurst NM, Myatt A, Schanler RJ. Growth and development of a hospital-based lactation program and mother's own milk bank. J Obstet Gynecol Neonatal Nurs 1998; 27:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/9\">",
"      Jones E. Strategies to promote preterm breastfeeding. Mod Midwife 1995; 5:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/10\">",
"      Meier PP, Engstrom JL, Mangurten HH, et al. Breastfeeding support services in the neonatal intensive-care unit. J Obstet Gynecol Neonatal Nurs 1993; 22:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/11\">",
"      Merewood A, Chamberlain LB, Cook JT, et al. The effect of peer counselors on breastfeeding rates in the neonatal intensive care unit: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2006; 160:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/12\">",
"      Sisk PM, Lovelady CA, Dillard RG, Gruber KJ. Lactation counseling for mothers of very low birth weight infants: effect on maternal anxiety and infant intake of human milk. Pediatrics 2006; 117:e67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/13\">",
"      Hill PD, Aldag JC. Milk volume on day 4 and income predictive of lactation adequacy at 6 weeks of mothers of nonnursing preterm infants. J Perinat Neonatal Nurs 2005; 19:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/14\">",
"      Henderson JJ, Hartmann PE, Newnham JP, Simmer K. Effect of preterm birth and antenatal corticosteroid treatment on lactogenesis II in women. Pediatrics 2008; 121:e92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/15\">",
"      Hill PD, Brown LP, Harker TL. Initiation and frequency of breast expression in breastfeeding mothers of LBW and VLBW infants. Nurs Res 1995; 44:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/16\">",
"      Groh-Wargo S, Toth A, Mahoney K, et al. The utility of a bilateral breast pumping system for mothers of premature infants. Neonatal Netw 1995; 14:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/17\">",
"      Jones E, Dimmock PW, Spencer SA. A randomised controlled trial to compare methods of milk expression after preterm delivery. Arch Dis Child Fetal Neonatal Ed 2001; 85:F91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/18\">",
"      Fewtrell MS, Lucas P, Collier S, et al. Randomized trial comparing the efficacy of a novel manual breast pump with a standard electric breast pump in mothers who delivered preterm infants. Pediatrics 2001; 107:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/19\">",
"      Hopkinson JM, Schanler RJ, Garza C. Milk production by mothers of premature infants. Pediatrics 1988; 81:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/20\">",
"      Parker LA, Sullivan S, Krueger C, et al. Effect of early breast milk expression on milk volume and timing of lactogenesis stage II among mothers of very low birth weight infants: a pilot study. J Perinatol 2012; 32:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/21\">",
"      Hill PD, Aldag JC, Chatterton RT. Initiation and frequency of pumping and milk production in mothers of non-nursing preterm infants. J Hum Lact 2001; 17:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/22\">",
"      Daly SE, Hartmann PE. Infant demand and milk supply. Part 2: The short-term control of milk synthesis in lactating women. J Hum Lact 1995; 11:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/23\">",
"      Kent JC, Mitoulas L, Cox DB, et al. Breast volume and milk production during extended lactation in women. Exp Physiol 1999; 84:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/24\">",
"      Hill PD, Ledbetter RJ, Kavanaugh KL. Breastfeeding patterns of low-birth-weight infants after hospital discharge. J Obstet Gynecol Neonatal Nurs 1997; 26:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/25\">",
"      Lawrence RA. Breastfeeding support benefits very low-birth-weight infants. Arch Pediatr Adolesc Med 2001; 155:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/26\">",
"      Schanler RJ. The use of human milk for premature infants. Pediatr Clin North Am 2001; 48:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/27\">",
"      Morton J, Hall JY, Wong RJ, et al. Combining hand techniques with electric pumping increases milk production in mothers of preterm infants. J Perinatol 2009; 29:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/28\">",
"      Daly SE, Di Rosso A, Owens RA, Hartmann PE. Degree of breast emptying explains changes in the fat content, but not fatty acid composition, of human milk. Exp Physiol 1993; 78:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/29\">",
"      Woodward DR, Rees B, Boon JA. Human milk fat content: within-feed variation. Early Hum Dev 1989; 19:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/30\">",
"      Valentine CJ, Hurst NM, Schanler RJ. Hindmilk improves weight gain in low-birth-weight infants fed human milk. J Pediatr Gastroenterol Nutr 1994; 18:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/31\">",
"      el-Mohandes AE, Schatz V, Keiser JF, Jackson BJ. Bacterial contaminants of collected and frozen human milk used in an intensive care nursery. Am J Infect Control 1993; 21:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/32\">",
"      Thompson N, Pickler RH, Munro C, Shotwell J. Contamination in expressed breast milk following breast cleansing. J Hum Lact 1997; 13:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/33\">",
"      Tully MR. Recommendations for handling of mother's own milk. J Hum Lact 2000; 16:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/34\">",
"      Goldblum RM, Garza C, Johnson CA, et al. Human milk banking I: Effects of container upon immunologic factors in mature milk. Nutr Res 1981; 1:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/35\">",
"      Williamson MT, Murti PK. Effects of storage, time, temperature, and composition of containers on biologic components of human milk. J Hum Lact 1996; 12:31.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.massmedboard.org/public/pdf/bisphenola_advisory.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/37\">",
"      Hamosh M, Ellis LA, Pollock DR, et al. Breastfeeding and the working mother: effect of time and temperature of short-term storage on proteolysis, lipolysis, and bacterial growth in milk. Pediatrics 1996; 97:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/38\">",
"      Hamosh M. Bioactive factors in human milk. Pediatr Clin North Am 2001; 48:69.",
"     </a>",
"    </li>",
"    <li>",
"     Jones F, Tully MR. Best Practice for Expressing, Storing and Handling Human Milk, 2nd ed, Human Milk Banking Association of North America, Inc, Raleigh, NC 2006.",
"    </li>",
"    <li>",
"     Robbins ST, Beker LT. Guidelines for Preparation of Formula and Breastmilk in Health Care Facilities: American Dietetic Association 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/41\">",
"      Slutzah M, Codipilly CN, Potak D, et al. Refrigerator storage of expressed human milk in the neonatal intensive care unit. J Pediatr 2010; 156:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/42\">",
"      Quan R, Yang C, Rubinstein S, et al. Effects of microwave radiation on anti-infective factors in human milk. Pediatrics 1992; 89:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/43\">",
"      Schanler RJ, Fraley JK, Lau C, et al. Breastmilk cultures and infection in extremely premature infants. J Perinatol 2011; 31:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/44\">",
"      Willeitner A. Transmission of cytomegalovirus (CMV) through human milk: are new breastfeeding policies required for preterm infants? Adv Exp Med Biol 2004; 554:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/45\">",
"      Moore ER, Anderson GC, Bergman N. Early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database Syst Rev 2007; :CD003519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/46\">",
"      Charpak N, Ruiz-Pelaez JG, Figueroa de C Z, Charpak Y. A randomized, controlled trial of kangaroo mother care: results of follow-up at 1 year of corrected age. Pediatrics 2001; 108:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/47\">",
"      Charpak N, Ruiz-Pel&aacute;ez JG, Figueroa de C Z, Charpak Y. Kangaroo mother versus traditional care for newborn infants &lt;/=2000 grams: a randomized, controlled trial. Pediatrics 1997; 100:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/48\">",
"      Hurst NM, Valentine CJ, Renfro L, et al. Skin-to-skin holding in the neonatal intensive care unit influences maternal milk volume. J Perinatol 1997; 17:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/49\">",
"      Tessier R, Cristo M, Velez S, et al. Kangaroo mother care and the bonding hypothesis. Pediatrics 1998; 102:e17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/50\">",
"      Gale G, Franck L, Lund C. Skin-to-skin (kangaroo) holding of the intubated premature infant. Neonatal Netw 1993; 12:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/51\">",
"      T&ouml;rnhage CJ, Stuge E, Lindberg T, Serenius F. First week kangaroo care in sick very preterm infants. Acta Paediatr 1999; 88:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/52\">",
"      Legault M, Goulet C. Comparison of kangaroo and traditional methods of removing preterm infants from incubators. J Obstet Gynecol Neonatal Nurs 1995; 24:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/53\">",
"      Karlsson V, Heinemann AB, Sj&ouml;rs G, et al. Early skin-to-skin care in extremely preterm infants: thermal balance and care environment. J Pediatr 2012; 161:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/54\">",
"      Kirsten GF, Bergman NJ, Hann FM. Kangaroo mother care in the nursery. Pediatr Clin North Am 2001; 48:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/55\">",
"      Anderson PO, Vald&eacute;s V. A critical review of pharmaceutical galactagogues. Breastfeed Med 2007; 2:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/56\">",
"      Sakha K, Behbahan AG. Training for perfect breastfeeding or metoclopramide: which one can promote lactation in nursing mothers? Breastfeed Med 2008; 3:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/57\">",
"      Ehrenkranz RA, Ackerman BA. Metoclopramide effect on faltering milk production by mothers of premature infants. Pediatrics 1986; 78:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/58\">",
"      Donovan TJ, Buchanan K. Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants. Cochrane Database Syst Rev 2012; 3:CD005544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/59\">",
"      Campbell-Yeo ML, Allen AC, Joseph KS, et al. Effect of domperidone on the composition of preterm human breast milk. Pediatrics 2010; 125:e107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/60\">",
"      da Silva OP, Knoppert DC, Angelini MM, Forret PA. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. CMAJ 2001; 164:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13657/abstract/61\">",
"      American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics 1994; 93:137.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5044 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-213.134.24.46-B0B7A2AA67-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13657=[""].join("\n");
var outline_f13_21_13657=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PARENTAL SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EFFECTS OF PREMATURITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MILK EXPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Breast pump selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Timing and frequency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Initiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Frequency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Inter-pumping intervals",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Milk volume",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hindmilk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      MILK COLLECTION AND STORAGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Milk collection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Milk storage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Containers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Temperature",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Aliquoting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Cultures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OPTIMIZING MILK PRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Breast emptying",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Bedside pumping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Tactile nipple stimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Skin-to-skin contact",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Galactagogues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/8/19593?source=related_link\">",
"      Approach to enteral nutrition in the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/12/36040?source=related_link\">",
"      Breastfeeding the preterm infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42616?source=related_link\">",
"      Breastfeeding: Parental education and support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=related_link\">",
"      Common problems of breastfeeding and weaning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=related_link\">",
"      Human milk feeding and fortification of human milk for premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=related_link\">",
"      Infant benefits of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8217?source=related_link\">",
"      Initiation of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1461?source=related_link\">",
"      Maternal and economic benefits of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/28/458?source=related_link\">",
"      Nutritional composition of human milk and preterm formula for the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/25/17813?source=related_link\">",
"      Patient information: Breast pumps (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/22/36194?source=related_link\">",
"      Patient information: Breast pumps (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6519?source=related_link\">",
"      Physiology of lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/1/32794?source=related_link\">",
"      Principles of medication use during lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/4/21576?source=related_link\">",
"      Sucking and swallowing disorders in the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_21_13658="Treatment of acute low back pain";
var content_f13_21_13658=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of acute low back pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Christopher L Knight, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Richard A Deyo, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Thomas O Staiger, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Joyce E Wipf, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Steven J Atlas, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/21/13658/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/21/13658/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Back pain is a common problem and a leading reason for all physician visits. Most cases are attributed to musculoligamentous injury or skeletal degenerative changes, although the differential diagnosis is broad. This discussion assumes that a diagnostic evaluation has excluded cancer, compression fracture, infection, visceral disease, or inflammatory spondylitis as a cause of back pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Wide variations in the use of pain medications, physical measures, injections, and surgery for back pain suggest professional uncertainty regarding optimal therapy. Evidence suggests overuse of imaging studies and surgery for back pain in the United States and some experts argue that the condition has been \"overmedicalized.\" Despite rapid increases in the use of imaging, opioid pain medications, injections, complementary and alternative medicine, and surgery, there is no clear evidence of improved functional status or declining work disability related to back pain.",
"   </p>",
"   <p>",
"    This discussion focuses on evidence and recommendations for the initial treatment of acute back pain (&lt;4 weeks duration). Management of patients with subacute (4 to 12 weeks) and chronic (&gt;12 weeks) back pain is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/24/19850?source=see_link\">",
"     \"Subacute and chronic low back pain: Pharmacologic and noninterventional treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39753?source=see_link\">",
"     \"Subacute and chronic low back pain: Nonsurgical interventional treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/5/34905?source=see_link\">",
"     \"Subacute and chronic low back pain: Surgical treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for acute low back pain is excellent. Only about one-third of patients with back pain seek medical care, so most apparently improve on their own. Up to 90 percent of patients seen within three days of onset recover within the first two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the prognosis is less favorable among a cross-section of patients who visit physician's offices, many of whom have chronic or recurrent pain. Since many patients improve with self-care, those who seek out physicians may have less favorable prognoses. Also, patients with persistent problems make multiple visits, and therefore office patients over-represent those who have a delayed recovery. Factors associated with persistent disabling back pain include maladaptive pain coping behaviors (eg, fear avoidance), nonorganic signs suggesting somatization, baseline function impairment, and lower general health status [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/2\">",
"     2",
"    </a>",
"    ]. Even so, primary care samples suggest that one-third of patients are substantially improved after just one week and two-thirds after seven weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recurrences are common, however, and may affect up to 40 to 50 percent of patients within six months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/4\">",
"     4",
"    </a>",
"    ] and 70 percent in 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/5\">",
"     5",
"    </a>",
"    ]. Similar to the initial episode, most recurrences have a favorable prognosis. Nonetheless, for many patients with back pain, the natural history mimics that of chronic conditions like asthma, which may be associated with chronic mild symptoms and intermittent exacerbations. In one prospective cohort study of patients with acute back pain seen in primary care, chronic back pain was diagnosed in 20 percent of patients within two years of their initial visit [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The natural history of sciatica, typically due to a herniated disc, may be somewhat less favorable than back pain without radicular symptoms although improvement is still the norm. Symptom improvement from sciatic pain is typically slower, but about a third are much improved in two weeks, and 75 percent after three months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/6\">",
"     6",
"    </a>",
"    ]. Among patients seeking specialty care, about 15 percent undergo surgery within six months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. It is estimated that among all patients with sciatica, only about 10 percent of patients ultimately undergo surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/9\">",
"     9",
"    </a>",
"    ]. Regression of the herniated part of the disc occurs on repeat MRI in about two-thirds of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This favorable prognosis is one reason why many disparate treatments appear to be effective for back pain. Nearly any treatment administered in the acute phase may appear to be effective, if most patients are destined to improve. Randomized controlled trials are therefore essential to determine whether a treatment actually results in faster or more sustained improvement than the natural history.",
"   </p>",
"   <p>",
"    Spinal stenosis, in contrast to routine back pain and herniated discs, is more likely to remain stable, though even here variation in intensity of symptoms is common. In one study, only 15 percent of patients improved over a four year period, another 15 percent deteriorated, and about 70 percent remained stable [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/12\">",
"     12",
"    </a>",
"    ]. A more recent study demonstrated stability in about 50 percent with a quarter either improving or worsening [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22776?source=see_link\">",
"     \"Lumbar spinal stenosis: Treatment and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many non-medical factors influence return to work. Back pain should rarely be permanently disabling, although many patients have beliefs to the contrary and reassurance is often an essential aspect of treatment. Return to work after an episode of low back pain may be challenging for social and economic reasons. Even with successful surgery resulting in symptomatic and functional improvement, patients with herniated discs may not return to work earlier than those who receive non-surgical treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ACTIVITY MODIFICATION AND BED REST",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bed rest was for decades considered standard therapy for patients with acute low back pain. Multiple randomized trials have now demonstrated that recovery from pain is equally rapid and complete without bed rest. A systematic review concluded that patients advised to rest in bed may even have slightly more pain and less functional recovery than those advised to remain ambulatory [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Randomized trials also suggest there is no advantage to bed rest for patients with sciatica. In one study, 183 patients with lumbosacral radicular symptoms were randomly assigned to bed rest or \"watchful waiting\" for two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/16\">",
"     16",
"    </a>",
"    ]. At two weeks, 70 percent of the bed rest and 65 percent of the watchful waiting group reported improvement (difference not statistically significant); at 12 weeks, 87 percent of both groups reported improvement, with no difference between the groups in pain intensity, functional status, or work absenteeism.",
"   </p>",
"   <p>",
"    Patients may fear that ongoing pain in the face of ambulation is a harbinger of permanent injury; reassurance to the contrary can be confidently offered. Patients should be told that they are not fragile, and that rapid return to normal activities of daily living is generally the best activity recommendation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Return-to-work recommendations must be individualized. A white collar office worker who controls the pace of his work, his position during work, and even his work hours, may often be able to return to work promptly. However, for those with ergonomically demanding jobs, pain may mandate some time away from the regular work place. Early return to the workplace and to a normal work schedule may have value even if the patient does not return immediately to usual duties. It may be valuable to contact the patient's work supervisor to determine if light duty options are available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PHARMACOTHERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Nonsteroidal antiinflammatory drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical experience supports the use of nonsteroidal antiinflammatory drugs (NSAIDs) in acute low back pain. A 2008 systematic review of 65 randomized trials of NSAID use for low back pain included a meta-analysis of 11 trials for acute low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/18\">",
"     18",
"    </a>",
"    ]. Global symptomatic improvement after one week was greater for patients treated with NSAIDs compared to placebo (RR 1.19; 95% CI 1.07-1.35). There was moderate evidence that NSAIDs were not significantly more effective than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    for symptom relief of acute low back pain (RR 1.23, 088-1.73), but NSAIDs were associated with more side effects.",
"   </p>",
"   <p>",
"    A randomized trial published subsequent to data retrieval for the 2008 systematic review evaluated two interventions (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/29/38352?source=see_link\">",
"     diclofenac",
"    </a>",
"    50 mg twice daily and spinal manipulation) in 240 patients presenting to their general practitioner with an episode of acute low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/19\">",
"     19",
"    </a>",
"    ]. All patients were counseled on the expected course of recovery, advised to remain active, and treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    1 g four times daily. There was no difference in time to recovery, defined as first pain-free day (HR 1.09, 95% CI 0.84-1.42), or in secondary outcomes of pain level, function, or perceived effect, for patients receiving NSAID treatment, manipulation, both, or neither. The authors propose that patients may not have received counseling and pain medication (acetaminophen) in previous trials that demonstrated some effectiveness for NSAID treatment. This trial suggests that there is little, if any, benefit of adding NSAID therapy to high-dose acetaminophen.",
"   </p>",
"   <p>",
"    In trials of newer NSAIDs, intramuscular",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/62/35808?source=see_link\">",
"     ketorolac",
"    </a>",
"    (60 mg) was comparable to intramuscular",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    for acute pain relief in the emergency department setting in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/20\">",
"     20",
"    </a>",
"    ]. The cyclooxygenase-2 (COX-2) inhibitors valdecoxib and etoricoxib (neither available in the United States market) have both shown efficacy for chronic back pain in placebo-controlled trials, but have not been studied in acute back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/21\">",
"     21",
"    </a>",
"    ]. Herbal non-steroidals may also be effective: willow bark extract, which contains salicylates, was equivalent to the COX-2 inhibitor rofecoxib in one randomized trial of patients with acute exacerbation of low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recommendations from 2007 joint practice guidelines of the American College of Physicians (ACP) and the American Pain Society (APS) advise either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    or NSAIDs as first line therapy for acute pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/23\">",
"     23",
"    </a>",
"    ]. For patients with acute low back pain and no increased risk for adverse effects (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Adverse effects'",
"    </a>",
"    below), NSAIDs could be recommended for up to two to four weeks.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     Ibuprofen",
"    </a>",
"    (400 to 600 mg four times daily) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/43/43705?source=see_link\">",
"     naproxen",
"    </a>",
"    (220 to 500 mg twice daily) are reasonable options, since they are inexpensive and available over the counter in the US. Doses should be decreased as tolerated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSAIDs of all varieties (non-selective, COX-2 selective, and herbal) have significant adverse effects. Nephrotoxicity is characteristic of both non-selective and COX-2 selective drugs. COX-2 selective NSAIDs have a lower risk of gastrointestinal toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/24\">",
"     24",
"    </a>",
"    ], although the reduction in risk is less than that of adding a proton pump inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=see_link\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An increased risk of cardiovascular adverse events was seen initially with rofecoxib and led to its withdrawal from the United States market [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/26\">",
"     26",
"    </a>",
"    ]. Valdecoxib was subsequently withdrawn as well. Subsequent reviews of observational data suggest that cardiovascular risk varies among NSAIDs; rofecoxib appears to confer greater risk than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/11/40120?source=see_link\">",
"     celecoxib",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/29/38352?source=see_link\">",
"     diclofenac",
"    </a>",
"    greater risk than most other non-selective NSAIDS [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All NSAID toxicities are more common in older patients. These medications, therefore, are best used in younger patients and those without significant renal, gastric, or cardiovascular comorbidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Acetaminophen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    in acute back pain is also supported more by experience than by evidence. There have been no randomized controlled trials intended to test the efficacy of acetaminophen in back pain. A systematic review of acetaminophen in osteoarthritis found it to be less effective than NSAIDs [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/28\">",
"     28",
"    </a>",
"    ]; however, the pathophysiologic overlap between chronic osteoarthritis and acute low back pain may be minimal.",
"   </p>",
"   <p>",
"    Hepatotoxicity is the primary concern with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    use. The risk of liver injury is dose-related, but the actual acetaminophen dose causing toxicity varies substantially from patient to patient. Hepatotoxicity risk increases in patients using alcohol concomitantly and may be compounded in patients who unknowingly take two or more acetaminophen-containing preparations [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/29\">",
"     29",
"    </a>",
"    ]. A randomized trial in healthy volunteers showed that ingestion of 4 g of acetaminophen daily for 14 days was associated with a &gt;30 percent incidence of liver enzymes that exceeded three times the upper limit of normal [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    is a reasonable option for most patients with acute low back pain, with perhaps less efficacy than NSAIDs (on the basis of minimal data). There is a small risk of severe hepatotoxicity with higher doses and a substantial risk of asymptomatic abnormalities in transaminases with therapeutic doses.",
"   </p>",
"   <p>",
"    The labeled dosing of 4 g per 24 hours is appropriate for most patients. Patients should be advised that many combination analgesics, both prescription and over-the-counter, contain",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ; labels should be carefully checked, and the total dose of acetaminophen taken into account when combining medications. Furthermore, it may be prudent to advise patients with a history of heavy alcohol use or other risk factors for hepatotoxicity to limit acetaminophen dose to 2 g per day or less.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Centrally-acting skeletal muscle relaxants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Centrally-acting skeletal muscle relaxants (SMRs) are a collection of drugs with similar physiologic effects (chiefly analgesia and sedation) and, at least subjectively, a degree of skeletal muscle relaxation or relief of spasm. Chemically, they are a diverse group of drugs which includes benzodiazepines,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/60/13254?source=see_link\">",
"     cyclobenzaprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/6/24677?source=see_link\">",
"     methocarbamol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32693?source=see_link\">",
"     carisoprodol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/37/40532?source=see_link\">",
"     chlorzoxazone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/61/41940?source=see_link\">",
"     metaxalone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/11/36021?source=see_link\">",
"     orphenadrine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/35/12855?source=see_link\">",
"     tizanidine",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Muscle relaxants have been studied in several randomized trials. A 2003 systematic review found high-quality evidence that non-benzodiazepine skeletal muscle relaxants are more effective than placebo for short-term relief of acute low back pain (RR 0.80, 95% CI 0.71 to 0.89) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/31\">",
"     31",
"    </a>",
"    ]. The comparative trials they reviewed showed little difference among the various drugs.",
"   </p>",
"   <p>",
"    A more recent review found more evidence for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/60/13254?source=see_link\">",
"     cyclobenzaprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/6/24677?source=see_link\">",
"     methocarbamol",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32693?source=see_link\">",
"     carisoprodol",
"    </a>",
"    than for other drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/32\">",
"     32",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/35/12855?source=see_link\">",
"     Tizanidine",
"    </a>",
"    interacts with CYP1A2 inhibitors, resulting in hypotension and increased sedation; it is contraindicated in patients receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    and should be avoided with other inhibitors of CYP1A2 (eg, other fluoroquinolones,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/9/10389?source=see_link\">",
"     mexiletine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/51/26423?source=see_link\">",
"     propafenone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/45/728?source=see_link\">",
"     famotidine",
"    </a>",
"    , oral contraceptives,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/27/35255?source=see_link\">",
"     ticlopidine",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The combination of a muscle relaxant and an NSAID provided the most effective symptom relief at one week in an observational study of over 200 patients seen for their first episode of back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/34\">",
"     34",
"    </a>",
"    ]. Subsequent randomized trial results have been mixed: a trial that compared the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/60/13254?source=see_link\">",
"     cyclobenzaprine",
"    </a>",
"    alone or in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    (1200 mg or 2400 mg daily dose) found similar outcomes for the treatment groups, while a trial comparing aceclofenac 100 mg twice daily with or without addition of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/35/12855?source=see_link\">",
"     tizanidine",
"    </a>",
"    2 mg twice daily found improved pain relief and decreased functional impairment with combination therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The primary adverse effects of muscle relaxants relate to their central nervous system activity: sedation and dizziness are common to all drugs within this class.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/37/40532?source=see_link\">",
"     Chlorzoxazone",
"    </a>",
"    has been associated with hepatotoxicity in rare cases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/37\">",
"     37",
"    </a>",
"    ]. Dependence and abuse potential are concerns with benzodiazepines.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32693?source=see_link\">",
"     Carisoprodol",
"    </a>",
"    also has abuse potential, particularly in patients with a history of substance abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/38\">",
"     38",
"    </a>",
"    ]; its first metabolite is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/43/19125?source=see_link\">",
"     meprobamate",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Muscle relaxants appear to benefit patients who can tolerate their adverse effects. Available comparative data suggest little difference between agents.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/60/13254?source=see_link\">",
"     Cyclobenzaprine",
"    </a>",
"    is a reasonable first choice drug, based on the volume of evidence. Benzodiazepines should not be used first line because of less evidence to support their use and concern about abuse potential. Muscle relaxants should generally be limited to relatively short-term therapy (one to three weeks).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Opioids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioid agonists are widely acknowledged to be among the therapeutic options for low back pain, but there are limited data on their efficacy and safety for this indication. Most recent studies focus on chronic back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"     Tramadol",
"    </a>",
"    is a non-opioid drug that acts at the opioid receptor. Several controlled trials in chronic back pain show that",
"    <span class=\"nowrap\">",
"     tramadol/",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"      acetaminophen",
"     </a>",
"    </span>",
"    tablets are more effective than placebo and have comparable efficacy to",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"      codeine",
"     </a>",
"     /acetaminophen",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/40-42\">",
"     40-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most other controlled trials compare sustained-release to short-acting opiates in the setting of chronic back pain and are not generalizable to acute back pain. The appropriate dosing regimen is also open to question. One trial comparing scheduled dosing of opiates to as-needed dosing found better outcomes in the scheduled dosing group [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adverse effects of opiates include sedation, confusion, nausea, and constipation. Respiratory depression is an issue at higher doses but rarely at the doses used for acute low back pain. As with other medications, older patients are more susceptible to these adverse effects. Patients given combination drugs containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    or NSAIDs should be advised not to use them concurrently with over-the-counter analgesics without carefully reviewing the contents, ideally with a health care professional.",
"   </p>",
"   <p>",
"    Misuse and abuse are a concern with opiates. Although rates of abuse of prescription opiates are rising in the United States, addiction and abuse are rare with short-term prescription for acute pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/44\">",
"     44",
"    </a>",
"    ], but more common for patients using opioids for treatment of chronic back pain, with reports of opioid abuse ranging from 30 to 45 percent in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/39,45\">",
"     39,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of definitive data, use of opiates for low back pain is a matter of clinical judgment. NSAIDs,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , and skeletal muscle relaxants may suffice for most patients. If opiates are used, it is advisable to limit to short term use and to consider scheduled rather than as-needed dosing. One strategy is to limit opioids to bedtime use to facilitate sleep, helping at-risk patients reduce the chances of developing dependence or tolerance compared to regular daytime use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are remarkably few clinical trials that specifically address the use of systemic steroids for acute low back pain. A number of small, early trials had negative findings for the effectiveness of systemic steroids for radicular pain, but the sample sizes were small [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. A subsequent trial found only transient pain reduction with bolus intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    for patients with radicular findings [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/48\">",
"     48",
"    </a>",
"    ]. A small randomized placebo-controlled trial of parenteral methylprednisolone in patients presenting to the emergency department with non-traumatic low back pain and a negative straight leg raise found no benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/49\">",
"     49",
"    </a>",
"    ]. The 2007 joint guidelines from the ACP and APS recommend against use of systemic glucocorticoids because of lack of proven benefit over placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In light of these findings, we do not recommend systemic corticosteroids in acute low back pain. If they are used, especially in high doses, patients should be advised of adverse effects, particularly insomnia, mood lability, and poor glycemic control in those with diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other medications, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    and other anticonvulsants, tricyclic antidepressants, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    patches, have been used in the setting of chronic back pain. Tricyclics have been found to be beneficial in the setting of chronic back pain but have not been studied for acute back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/50\">",
"     50",
"    </a>",
"    ]. In the absence of data or significant clinical experience, we do not recommend the use of lidocaine patches, anticonvulsants, or antidepressants in treatment of acute low back pain.",
"   </p>",
"   <p>",
"    Intravenous infusions of tumor necrosis factor alpha (TNF-alpha) inhibitors in patients with acute sciatica have not been demonstrated to have benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/51\">",
"     51",
"    </a>",
"    ]. Injections of TNF-alpha inhibitors have also been studied. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Injections'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     EXERCISE AND OTHER PHYSICAL MODALITIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Exercise and exercise therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be encouraged to walk and resume normal daily activities as quickly as possible.",
"   </p>",
"   <p>",
"    Although some studies do show modest efficacy of exercise therapy in selected cases of acute low back pain (LBP) (less than four weeks) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/52,53\">",
"     52,53",
"    </a>",
"    ], systematic reviews have not clearly demonstrated a treatment benefit of generalized exercise therapy compared to other conservative treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. As an example, in one systematic review of 11 randomized trials of exercise in patients with acute LBP, exercise therapy was not more effective than no treatment or other conservative treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/55\">",
"     55",
"    </a>",
"    ], which included",
"    <span class=\"nowrap\">",
"     NSAIDs/other",
"    </span>",
"    analgesics, patient education programs,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    advice to stay active.",
"   </p>",
"   <p>",
"    Observational studies have provided conflicting results regarding the value of early physical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. There is modest evidence that patients at high risk of developing chronic pain may benefit from early psychologically-informed physical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/58\">",
"     58",
"    </a>",
"    ], though only a small percent of these patients had symptoms for less than four weeks and the role of exercise in this situation is uncertain.",
"   </p>",
"   <p>",
"    Exercises specifically targeting the back are not indicated, as there is little evidence to suggest that exercise therapy is effective for patients with acute low back pain. Once the acute phase has subsided, exercise may help prevent recurrences. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/43/6841?source=see_link\">",
"     \"Exercise-based therapy for low back pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Spinal manipulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal manipulation therapy is provided by a number of health professionals: chiropractors, osteopaths, massage therapists, and many physical therapists. Manipulative therapy may involve low-velocity mobilization or manipulation with a high velocity thrust that stretches a joint (spinal structures, in the case of back pain) beyond the normal end-range of voluntary movement.",
"   </p>",
"   <p>",
"    Manipulative therapy, primarily high-thrust chiropractic manipulation, has been relatively well studied in acute low back pain. One systematic review found that spinal manipulation was more effective than sham therapy and comparable in efficacy to conventional medical therapy in both acute and chronic low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/59\">",
"     59",
"    </a>",
"    ]. Another review found that combined chiropractic interventions (including more modalities than manipulation) improved pain in the short- and medium-term, but saw no effect on long term pain, although the studies reviewed were small and showed risk of bias [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/60\">",
"     60",
"    </a>",
"    ]. In addition, a number of individual randomized trials show somewhat conflicting results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One trial included 680 patients with acute, subacute, or chronic back pain seen in an HMO [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/61\">",
"       61",
"      </a>",
"      ]. The patients were randomly assigned to one of four groups: chiropractic care alone (manipulation and mobilization), chiropractic care plus physical modalities (heat or cold, ultrasound, electrical muscle stimulation), medical care alone, or medical care plus physical therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/61\">",
"       61",
"      </a>",
"      ]. At 18-month follow-up, patients who received chiropractic care alone showed a nonsignificant improvement in pain, disability, and remission rate compared to medical care alone (RR remission 1.29, 95% CI 0.8-2.07). Physical modalities did not augment the response to chiropractic care, but physical therapy improved response rates for patients in the medical care group. Patients who received either chiropractic care or physical therapy perceived greater benefit than those in the medical care group alone.",
"     </li>",
"     <li>",
"      In a randomized trial of 444 patients with acute low back pain comparing usual care versus treatment of patient choice (chiropractic, acupuncture, or massage therapy), patients in both groups had the same symptom response rate at five weeks, but patient satisfaction was significantly higher with therapy allowing patient choice [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a randomized trial of 240 patients with acute low back pain, patients who were randomly assigned to treatment arms that included spinal manipulation, mostly low-velocity mobilization, did not recover more quickly than those who received sham manipulation therapy (detuned pulsed ultrasound) (HR 1.01, 95% CI 0.77-1.31) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/19\">",
"       19",
"      </a>",
"      ]. Therapy was provided two or three times a week for four weeks and all patients received counseling and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      treatment.",
"     </li>",
"     <li>",
"      In a randomized trial of 104 patients with acute low back pain comparing usual care (advice and analgesics) with or without manipulation, there was no difference in reduction of pain or analgesic consumption, and no change in long-term disability [",
"      <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon the available evidence, manipulation is as effective as conventional medical therapy for acute low back pain. Integrating it into the therapeutic plan for individual patients should depend upon their preferences and access to this type of intervention.",
"   </p>",
"   <p>",
"    There is little evidence to guide the duration of therapy. Most clinical trials evaluated courses of twice weekly manipulation for two to three weeks, and none lasted more than nine weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/64\">",
"     64",
"    </a>",
"    ]. Older American guidelines suggest that treatment last no longer than one month if patients are not improving [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/65\">",
"     65",
"    </a>",
"    ]; more recent European guidelines suggest \"short\" courses of therapy. There is no evidence that manipulation reduces the risk of recurrence of back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spinal manipulation is also used for treatment of non-acute LBP and other musculoskeletal conditions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41222?source=see_link\">",
"     \"Spinal manipulation in the treatment of musculoskeletal pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Massage and yoga",
"    </span>",
"    &nbsp;&mdash;&nbsp;A limited number of studies have evaluated massage and yoga in acute low back pain. Massage and yoga have both been studied in the setting of chronic low back pain. In the study cited above, patients with acute low back pain who elected massage therapy, compared with control patients who had usual care, had the same symptom response rate at five weeks, although demonstrated higher patient satisfaction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A randomized controlled trial of viniyoga found it to be superior to conventional exercise or self-care, but was limited by the fact that the yoga program was designed and administered by a single practitioner, which raises concerns about generalizability [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patient expectations may play an important role in the benefit of these and other treatments. In one trial of massage versus acupuncture, patients were asked prior to randomization to rate the likelihood that each treatment would help. Patients who were randomized to receive the treatment they thought would be most helpful had substantially better outcomes than those allocated to the opposite group [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Acupuncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acupuncture and dry-needling have both been studied in low back pain, although predominantly for chronic symptoms. The techniques differ in that acupuncture points are typically determined by a traditional Chinese map linking specified points and lines (meridians) to physiologic variables and the flow of energy in the body. There are several schools and techniques. Dry-needling involves the use of needles (frequently acupuncture needles) inserted directly at points of myofascial pain to try to relieve",
"    <span class=\"nowrap\">",
"     pain/tension",
"    </span>",
"    at those points. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/27/7607?source=see_link\">",
"     \"Acupuncture for rheumatic conditions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Randomized trials of acupuncture and dry-needling tend to be small and heterogeneous in methodology, and blinding is difficult. Most available studies were reviewed in a 2005 systematic review that concluded that there is moderate evidence of short-term benefit to support the use of acupuncture in chronic low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/69\">",
"     69",
"    </a>",
"    ]. It appears to be better than no treatment or sham treatment and equivalent to NSAIDS, manipulation, and massage. Some data suggested additional benefit when acupuncture was combined with other therapies. Three acupuncture trials for acute low back pain were identified in this review; these studies found positive results, but the quality of the trials was too poor to draw definitive conclusions. Acupuncture, as performed in these studies, was safe with no major adverse events in any of the trials; significant adverse outcomes from acupuncture remain a reportable phenomenon.",
"   </p>",
"   <p>",
"    In general, acupuncture is a safe intervention, with reasonable data for efficacy in chronic back pain, and non-definitive but positive studies in acute back pain. Acupuncture may be a reasonable option for interested patients with access to an acupuncturist. Data are not available for the outcomes of dry-needling in the treatment of acute low back pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Cold and heat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Application of cold is often recommended for patients with acute back pain, with the rationale that it may help reduce edema, as in treating an ankle sprain. However, neither heat nor cold applied superficially penetrates far below the skin. A systematic review was unable to find sufficient evidence for a benefit of cold in treating low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Heat is often applied (using hot water bottles, soft heated packs filled with grain, hot towels, hot baths, saunas, steam, heat wraps, electric heating pads, or infrared heat lamps) with the rationale that it may reduce muscle spasm. Industry-sponsored trials suggest that a heat wrap may significantly reduce pain within five days among patients with acute and subacute low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. Another trial suggested that a heated blanket significantly reduced acute low back pain immediately after application [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/73\">",
"     73",
"    </a>",
"    ]. A systematic review found moderate evidence that a heat wrap may reduce pain and disability for patients with pain of less than three months duration, though the benefit was relatively small and short-lived [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     OTHER NON-DRUG TREATMENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Traction, corsets, and braces",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review identified 25 randomized trials of traction for low back pain, with or without sciatica. Only five trials were considered high quality, but the conclusion was that traction provides no significant benefit in short or long-term outcomes for low back pain patients with or without sciatica [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Corsets to limit spine movement have sometimes been advocated for preventing back pain in work sites that require occasional lifting. Randomized trials, however, suggest little benefit from this preventive effort [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/75-77\">",
"     75-77",
"    </a>",
"    ]. There is also little evidence to suggest that corsets or braces have therapeutic value for most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Mattress recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of mattresses has not been studied in acute low back pain. The traditional teaching of recommending hard mattresses is called into question by a study in patients with chronic low back pain, which found better outcomes for medium-firm versus firm mattresses [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/78\">",
"     78",
"    </a>",
"    ]. Responses to various mattresses are likely to be highly individualized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Patient education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient education is an intuitively important aspect of care. Studies that have evaluated education commonly use educational interventions as a control; in general, educational interventions are modestly inferior to other active treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/75,79-81\">",
"     75,79-81",
"    </a>",
"    ]. Our view is that patient education is necessary, but not sufficient, to result in improved outcomes.",
"   </p>",
"   <p>",
"    Education should include information about the causes of back pain, favorable prognosis, generally minimal value of diagnostic testing, activity and work recommendations, and when to contact a physician [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/79\">",
"     79",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Information for patients'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     INJECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of injections have been advocated for patients with back pain and sciatica. These include injections with local anesthetics, proliferant-sclerosing solutions (known as prolotherapy or sclerotherapy), oxygen-ozone mixtures, botulinum toxin, and TNF-alpha inhibitors. Only modest evidence is available for most of these [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/82-86\">",
"     82-86",
"    </a>",
"    ]. The injections may target trigger points, the epidural space, or be directed at the facet joint or sacroiliac joint.",
"   </p>",
"   <p>",
"    Trigger points injections remain a point of controversy. An Institute of Medicine report on pain treatment included separate chapters representing opposing opinions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/87\">",
"     87",
"    </a>",
"    ]. There is limited available clinical trial evidence to evaluate their effectiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Epidural steroid injections have been used for decades, mainly for patients with radicular signs and symptoms. The rationale is that herniated discs in contact with nerve roots elicit an inflammatory response and nerve root edema that may be reduced by local application of corticosteroids. Randomized trial results are conflicting, but several suggest that these injections offer short-term symptom relief for some patients with sciatica [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/83,88\">",
"     83,88",
"    </a>",
"    ]. Epidural steroids have not been shown to reduce rates of subsequent disc surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/89,90\">",
"     89,90",
"    </a>",
"    ]. There is no evidence to suggest that these injections are effective for patients with back pain alone. It remains unclear whether epidural steroids are more effective than systemic corticosteroids.",
"   </p>",
"   <p>",
"    The facet joints are richly innervated synovial joints that undergo degenerative changes, like other joints that become osteoarthritic. However, it is difficult or impossible to identify a group of patients whose pain originates from the facet joints on a clinical or imaging basis. Randomized trials comparing corticosteroid injections of the facet joints with saline injections generally suggest no advantage to corticosteroid injections [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/82,91\">",
"     82,91",
"    </a>",
"    ]. Controversy regarding the efficacy of these injections continues, despite these observations, and the evidence is sparse.",
"   </p>",
"   <p>",
"    Evidence supporting sacroiliac joint injections is even sparser than for other types of injections. Patients with spondyloarthropathies, such as ankylosing spondylitis, have well-documented sacroiliitis, and symptoms in these patients may respond to corticosteroid injection. In the absence of inflammatory spondyloarthropathy, there is little evidence that sacroiliac pain can be accurately diagnosed by either physical examination or imaging. We were unable to identify randomized trials on the efficacy of sacroiliac joint injection.",
"   </p>",
"   <p>",
"    Prolotherapy (from \"proliferant therapy\"), or \"sclerotherapy\" in the osteopathic literature, is based on the theory that some back pain results from weakened or damaged ligaments. Injection with irritant solutions is believed to strengthen the ligaments and reduce pain and disability. The materials injected typically include some combination of dextrose,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/32/14852?source=see_link\">",
"     glycerin",
"    </a>",
"    , phenol, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    . This is generally reserved for chronic back pain, and randomized trials do not support the efficacy of these injections in the absence of co-interventions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a blinded, multicenter trial of oxygen-ozone injection treatment for acute low back pain, 60 patients with lumbar disc herniation were randomly assigned to intramuscular paravertebral injections of oxygen-ozone (three",
"    <span class=\"nowrap\">",
"     infiltrations/week",
"    </span>",
"    for five weeks) versus sham therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/85\">",
"     85",
"    </a>",
"    ]. After six months of follow-up, patients receiving oxygen-ozone therapy were more likely to become pain-free (61 versus 33 percent). However, the improvement rate in the control arm was low, and the method described for sham therapy may not have provided adequate blinding. Further study is warranted before this therapy can be recommended.",
"   </p>",
"   <p>",
"    Botulinum toxin injections have not been well studied. A single small randomized trial (n = 31) compared paravertebral injections of botulinum toxin with saline injections and found significant benefit of botulinum toxin up to eight weeks after injection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/86\">",
"     86",
"    </a>",
"    ]. Confirmation in larger studies is needed before sound recommendations can be made.",
"   </p>",
"   <p>",
"    Tumor necrosis factor (TNF)-alpha has been implicated in the pathogenesis of radiculopathy and discogenic back pain, but few studies have evaluated the effects of injections of TNF-alpha inhibitors on acute low back pain. In one trial, 61 patients with severe acute radicular pain from herniated disc were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/24/39303?source=see_link\">",
"     adalimumab",
"    </a>",
"    injections or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/92\">",
"     92",
"    </a>",
"    ]. At six months, the difference in mean pain score was not significantly different between the two groups (mean difference on visual analog scale 0-100 mm, 13.8, 95% CI -11.5 to 39.0).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ergonomic design of strenuous job tasks in the workplace is an intuitively attractive preventive measure. An entire industry has been built around this premise, despite little supporting evidence. Rigorous evaluations of such interventions are difficult, because of heterogeneity in job tasks, restrictions imposed by labor and management, regulatory requirements, the difficulty of blinding, among many other factors. However, there is at least modest evidence from a clinical trial in which entire companies were randomly allocated to intervention or control conditions, suggesting that ergonomic design of job tasks may facilitate return to work and reduce the chronic nature of pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exercise intervention may have some value both in preventing first episodes of back pain and in preventing recurrences after patients have had back pain. The relatively few randomized trials are of low quality but are consistent in suggesting a benefit for reducing the incidence or perception of back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/76,94\">",
"     76,94",
"    </a>",
"    ]. A systematic review suggested better evidence for prevention of recurrence when the exercise program is initiated after treatment of the initial episode is complete [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/95\">",
"     95",
"    </a>",
"    ]. There appears to be little if any value to the use of corsets as a preventive measure [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/75\">",
"     75",
"    </a>",
"    ]. There is no evidence that smoking cessation or weight loss in appropriate patients effectively prevents back pain episodes; however, there are multiple validated other health-related reasons to promote these goals [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/7/36978?source=see_link\">",
"       \"Patient information: Low back pain in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/44/40642?source=see_link\">",
"       \"Patient information: Spinal stenosis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/62/41954?source=see_link\">",
"       \"Patient information: Herniated disc (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/47/8950?source=see_link\">",
"       \"Patient information: Low back pain in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, several excellent books for patients are cited below [",
"    <a class=\"abstract\" href=\"UTD.htm?13/21/13658/abstract/97-99\">",
"     97-99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute musculoskeletal low back pain is common and carries an excellent prognosis; high rates of improvement in the control group are the norm for controlled trials of acute low back pain. Multiple non-biologic factors may influence return to work. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend NOT advising patients with acute low back pain to remain at bed rest (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Patients who are treated for acute back pain with bed rest have more pain and slower recovery than ambulatory patients. Activity modification should generally be minimal, with patients returning to activities of daily living as soon as possible, and to work as soon as feasible. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Activity modification and bed rest'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy should focus on temporary symptomatic relief, to maximize patient comfort. We suggest short-term treatment with either an NSAID or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). NSAIDs might be considered for younger patients without significant renal, gastric, or cardiovascular comorbidity, and acetaminophen for patients without hepatic compromise who cannot tolerate NSAIDs. There appears to be no advantage to adding NSAID therapy to high-dose acetaminophen. Patients who can tolerate the sedating effects may also benefit from a non-benzodiazepine muscle relaxant (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/60/13254?source=see_link\">",
"       cyclobenzaprine",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). Data conflict on the benefit of combination therapy (muscle relaxant plus NSAID) versus monotherapy; for patients with moderate to severe pain or who are not responding to monotherapy, we suggest combination therapy, using muscle relaxants before bedtime and NSAIDs through the day (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest not prescribing systemic glucocorticoids for patients with low back pain, either with or without sciatica (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Opioid therapy is occasionally indicated for severe pain, and should be prescribed for short-term use on a fixed schedule, rather than as-needed. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that manipulation treatment be discussed as an option for patients who have access to such therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We also suggest not referring patients with acute low back pain for injection treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Acupuncture, massage, and yoga have only been evaluated in patients with chronic back pain, and evidence-based recommendations cannot be made for acute back pain. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Exercise and other physical modalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many additional treatment strategies have been advocated for managing acute low back pain but have not been demonstrated to be effective. Some of these interventions, however, do have a role in the management of chronic low back pain. High-quality evidence shows no benefit to exercise therapy in the initial two to three weeks, and no benefit to corsets, braces, or traction therapy. We suggest not referring patients for physical therapy in the initial two to three weeks (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Psychologically-informed physical therapy may be useful for patients whose psychosocial features suggest a high risk of chronicity. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Exercise and exercise therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with severe acute radicular symptoms who have failed a brief trial of conservative management, we suggest discussing the potential role for epidural steroid injections (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Other non-drug treatments'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Injections'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/1\">",
"      Coste J, Delecoeuillerie G, Cohen de Lara A, et al. Clinical course and prognostic factors in acute low back pain: an inception cohort study in primary care practice. BMJ 1994; 308:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/2\">",
"      Chou R, Shekelle P. Will this patient develop persistent disabling low back pain? JAMA 2010; 303:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/3\">",
"      Cherkin DC, Deyo RA, Street JH, Barlow W. Predicting poor outcomes for back pain seen in primary care using patients' own criteria. Spine (Phila Pa 1976) 1996; 21:2900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/4\">",
"      Mehling WE, Gopisetty V, Bartmess E, et al. The prognosis of acute low back pain in primary care in the United States: a 2-year prospective cohort study. Spine (Phila Pa 1976) 2012; 37:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/5\">",
"      Pengel LH, Herbert RD, Maher CG, Refshauge KM. Acute low back pain: systematic review of its prognosis. BMJ 2003; 327:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/6\">",
"      Vroomen PC, de Krom MC, Knottnerus JA. Predicting the outcome of sciatica at short-term follow-up. Br J Gen Pract 2002; 52:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/7\">",
"      Vroomen PC, de Krom MC, Knottnerus JA. When does the patient with a disc herniation undergo lumbosacral discectomy? J Neurol Neurosurg Psychiatry 2000; 68:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/8\">",
"      Bush K, Cowan N, Katz DE, Gishen P. The natural history of sciatica associated with disc pathology. A prospective study with clinical and independent radiologic follow-up. Spine (Phila Pa 1976) 1992; 17:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/9\">",
"      Frymoyer JW. Back pain and sciatica. N Engl J Med 1988; 318:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/10\">",
"      Bozzao A, Gallucci M, Masciocchi C, et al. Lumbar disk herniation: MR imaging assessment of natural history in patients treated without surgery. Radiology 1992; 185:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/11\">",
"      Delauche-Cavallier MC, Budet C, Laredo JD, et al. Lumbar disc herniation. Computed tomography scan changes after conservative treatment of nerve root compression. Spine (Phila Pa 1976) 1992; 17:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/12\">",
"      Johnsson KE, Ros&eacute;n I, Ud&eacute;n A. The natural course of lumbar spinal stenosis. Clin Orthop Relat Res 1992; :82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/13\">",
"      Atlas SJ, Keller RB, Wu YA, et al. Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976) 2005; 30:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/14\">",
"      Atlas SJ, Chang Y, Kammann E, et al. Long-term disability and return to work among patients who have a herniated lumbar disc: the effect of disability compensation. J Bone Joint Surg Am 2000; 82:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/15\">",
"      Dahm KT, Brurberg KG, Jamtvedt G, Hagen KB. Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica. Cochrane Database Syst Rev 2010; :CD007612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/16\">",
"      Vroomen PC, de Krom MC, Wilmink JT, et al. Lack of effectiveness of bed rest for sciatica. N Engl J Med 1999; 340:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/17\">",
"      Malmivaara A, H&auml;kkinen U, Aro T, et al. The treatment of acute low back pain--bed rest, exercises, or ordinary activity? N Engl J Med 1995; 332:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/18\">",
"      Roelofs PD, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2008; :CD000396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/19\">",
"      Hancock MJ, Maher CG, Latimer J, et al. Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial. Lancet 2007; 370:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/20\">",
"      Veenema KR, Leahey N, Schneider S. Ketorolac versus meperidine: ED treatment of severe musculoskeletal low back pain. Am J Emerg Med 2000; 18:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/21\">",
"      Coats TL, Borenstein DG, Nangia NK, Brown MT. Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial. Clin Ther 2004; 26:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/22\">",
"      Chrubasik S, K&uuml;nzel O, Model A, et al. Treatment of low back pain with a herbal or synthetic anti-rheumatic: a randomized controlled study. Willow bark extract for low back pain. Rheumatology (Oxford) 2001; 40:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/23\">",
"      Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007; 147:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/24\">",
"      Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/25\">",
"      Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006; 101:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/26\">",
"      Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001; 286:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/27\">",
"      McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006; 296:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/28\">",
"      Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006; :CD004257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/29\">",
"      Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/30\">",
"      Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006; 296:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/31\">",
"      van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003; :CD004252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/32\">",
"      Beebe FA, Barkin RL, Barkin S. A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther 2005; 12:151.",
"     </a>",
"    </li>",
"    <li>",
"     www.fda.gov/medwatch/SAFETY/2007/safety07.htm#Zanaflex (Accessed on October 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/34\">",
"      Cherkin DC, Wheeler KJ, Barlow W, Deyo RA. Medication use for low back pain in primary care. Spine (Phila Pa 1976) 1998; 23:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/35\">",
"      Pareek A, Chandurkar N, Chandanwale AS, et al. Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. Eur Spine J 2009; 18:1836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/36\">",
"      Childers MK, Borenstein D, Brown RL, et al. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial. Curr Med Res Opin 2005; 21:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/37\">",
"      Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004; 28:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/38\">",
"      Reeves RR, Carter OS, Pinkofsky HB, et al. Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis 1999; 18:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/39\">",
"      Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/40\">",
"      Mullican WS, Lacy JR, TRAMAP-ANAG-006 Study Group. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial. Clin Ther 2001; 23:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/41\">",
"      Peloso PM, Fortin L, Beaulieu A, et al. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol 2004; 31:2454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/42\">",
"      Ruoff GE, Rosenthal N, Jordan D, et al. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 2003; 25:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/43\">",
"      Fordyce WE, Brockway JA, Bergman JA, Spengler D. Acute back pain: a control-group comparison of behavioral vs traditional management methods. J Behav Med 1986; 9:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/44\">",
"      Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/45\">",
"      Reid MC, Engles-Horton LL, Weber MB, et al. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002; 17:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/46\">",
"      Porsman O, Friis H. Prolapsed lumbar disc treated with intramuscularly administered dexamethasonephosphate. A prospectively planned, double-blind, controlled clinical trial in 52 patients. Scand J Rheumatol 1979; 8:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/47\">",
"      Hedeboe J, Buhl M, Ramsing P. Effects of using dexamethasone and placebo in the treatment of prolapsed lumbar disc. Acta Neurol Scand 1982; 65:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/48\">",
"      Finckh A, Zufferey P, Schurch MA, et al. Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial. Spine (Phila Pa 1976) 2006; 31:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/49\">",
"      Friedman BW, Holden L, Esses D, et al. Parenteral corticosteroids for Emergency Department patients with non-radicular low back pain. J Emerg Med 2006; 31:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/50\">",
"      Staiger TO, Gaster B, Sullivan MD, Deyo RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine (Phila Pa 1976) 2003; 28:2540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/51\">",
"      Korhonen T, Karppinen J, Paimela L, et al. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial. Spine (Phila Pa 1976) 2006; 31:2759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/52\">",
"      Brennan GP, Fritz JM, Hunter SJ, et al. Identifying subgroups of patients with acute/subacute \"nonspecific\" low back pain: results of a randomized clinical trial. Spine (Phila Pa 1976) 2006; 31:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/53\">",
"      Fritz JM, Delitto A, Erhard RE. Comparison of classification-based physical therapy with therapy based on clinical practice guidelines for patients with acute low back pain: a randomized clinical trial. Spine (Phila Pa 1976) 2003; 28:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/54\">",
"      Faas A. Exercises: which ones are worth trying, for which patients, and when? Spine (Phila Pa 1976) 1996; 21:2874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/55\">",
"      Hayden JA, van Tulder MW, Malmivaara A, Koes BW. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev 2005; :CD000335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/56\">",
"      Gellhorn AC, Chan L, Martin B, Friedly J. Management patterns in acute low back pain: the role of physical therapy. Spine (Phila Pa 1976) 2012; 37:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/57\">",
"      Sinclair SJ, Hogg-Johnson SH, Mondloch MV, Shields SA. The effectiveness of an early active intervention program for workers with soft-tissue injuries. The Early Claimant Cohort Study. Spine (Phila Pa 1976) 1997; 22:2919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/58\">",
"      Fritz JM, Beneciuk JM, George SZ. Relationship between categorization with the STarT Back Screening Tool and prognosis for people receiving physical therapy for low back pain. Phys Ther 2011; 91:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/59\">",
"      Assendelft WJ, Morton SC, Yu EI, et al. Spinal manipulative therapy for low back pain. Cochrane Database Syst Rev 2004; :CD000447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/60\">",
"      Walker BF, French SD, Grant W, Green S. Combined chiropractic interventions for low-back pain. Cochrane Database Syst Rev 2010; :CD005427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/61\">",
"      Hurwitz EL, Morgenstern H, Kominski GF, et al. A randomized trial of chiropractic and medical care for patients with low back pain: eighteen-month follow-up outcomes from the UCLA low back pain study. Spine (Phila Pa 1976) 2006; 31:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/62\">",
"      Eisenberg DM, Post DE, Davis RB, et al. Addition of choice of complementary therapies to usual care for acute low back pain: a randomized controlled trial. Spine (Phila Pa 1976) 2007; 32:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/63\">",
"      J&uuml;ni P, Battaglia M, N&uuml;esch E, et al. A randomised controlled trial of spinal manipulative therapy in acute low back pain. Ann Rheum Dis 2009; 68:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/64\">",
"      Airaksinen O, Brox JI, Cedraschi C, et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006; 15 Suppl 2:S192.",
"     </a>",
"    </li>",
"    <li>",
"     Bigos S, Bowyer O, Braen G, et al. Acute low back pain in adults. Clinic Practice Guideline No. 14. Agency for Health Care Policy and Research; US Department of Health and Human Services, Rockville, MD 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/66\">",
"      Cherkin DC, Deyo RA, Batti&eacute; M, et al. A comparison of physical therapy, chiropractic manipulation, and provision of an educational booklet for the treatment of patients with low back pain. N Engl J Med 1998; 339:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/67\">",
"      Sherman KJ, Cherkin DC, Erro J, et al. Comparing yoga, exercise, and a self-care book for chronic low back pain: a randomized, controlled trial. Ann Intern Med 2005; 143:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/68\">",
"      Kalauokalani D, Cherkin DC, Sherman KJ, et al. Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa 1976) 2001; 26:1418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/69\">",
"      Furlan AD, van Tulder MW, Cherkin DC, et al. Acupuncture and dry-needling for low back pain. Cochrane Database Syst Rev 2005; :CD001351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/70\">",
"      French SD, Cameron M, Walker BF, et al. Superficial heat or cold for low back pain. Cochrane Database Syst Rev 2006; :CD004750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/71\">",
"      Nadler SF, Steiner DJ, Erasala GN, et al. Continuous low-level heatwrap therapy for treating acute nonspecific low back pain. Arch Phys Med Rehabil 2003; 84:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/72\">",
"      Nadler SF, Steiner DJ, Petty SR, et al. Overnight use of continuous low-level heatwrap therapy for relief of low back pain. Arch Phys Med Rehabil 2003; 84:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/73\">",
"      Nuhr M, Hoerauf K, Bertalanffy A, et al. Active warming during emergency transport relieves acute low back pain. Spine (Phila Pa 1976) 2004; 29:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/74\">",
"      Clarke JA, van Tulder MW, Blomberg SE, et al. Traction for low-back pain with or without sciatica. Cochrane Database Syst Rev 2007; :CD003010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/75\">",
"      van Poppel MN, Koes BW, van der Ploeg T, et al. Lumbar supports and education for the prevention of low back pain in industry: a randomized controlled trial. JAMA 1998; 279:1789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/76\">",
"      van Poppel MN, Hooftman WE, Koes BW. An update of a systematic review of controlled clinical trials on the primary prevention of back pain at the workplace. Occup Med (Lond) 2004; 54:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/77\">",
"      Van Tulder MW, Jellema P, van Poppel MN, et al. Lumbar supports for prevention and treatment of low back pain. Cochrane Database Syst Rev 2000; :CD001823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/78\">",
"      Kovacs FM, Abraira V, Pe&ntilde;a A, et al. Effect of firmness of mattress on chronic non-specific low-back pain: randomised, double-blind, controlled, multicentre trial. Lancet 2003; 362:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/79\">",
"      Atlas SJ, Deyo RA. Evaluating and managing acute low back pain in the primary care setting. J Gen Intern Med 2001; 16:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/80\">",
"      Cherkin DC, Deyo RA, Street JH, et al. Pitfalls of patient education. Limited success of a program for back pain in primary care. Spine (Phila Pa 1976) 1996; 21:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/81\">",
"      Daltroy LH, Iversen MD, Larson MG, et al. A controlled trial of an educational program to prevent low back injuries. N Engl J Med 1997; 337:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/82\">",
"      Nelemans PJ, deBie RA, deVet HC, Sturmans F. Injection therapy for subacute and chronic benign low back pain. Spine (Phila Pa 1976) 2001; 26:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/83\">",
"      Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of epidural steroid injections for low-back pain and sciatica: a systematic review of randomized clinical trials. Pain 1995; 63:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/84\">",
"      Yelland MJ, Mar C, Pirozzo S, et al. Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev 2004; :CD004059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/85\">",
"      Paoloni M, Di Sante L, Cacchio A, et al. Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: a multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine (Phila Pa 1976) 2009; 34:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/86\">",
"      Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology 2001; 56:1290.",
"     </a>",
"    </li>",
"    <li>",
"     Institute of Medicine. Committee on Pain, Disability, and Chronic Illness Behavior. Pain and disability: Clinical, behavioral, and public policy perspectives, Osterweis M, Kleinman A, Mechanic D (Eds), National Academy Press, Washington, DC 1987.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/88\">",
"      Pinto RZ, Maher CG, Ferreira ML, et al. Epideral corticosteroid injections in the management of sciatica: A systematic review and meta-analysis. Ann Intern Med 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/89\">",
"      Carette S, Leclaire R, Marcoux S, et al. Epidural corticosteroid injections for sciatica due to herniated nucleus pulposus. N Engl J Med 1997; 336:1634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/90\">",
"      Wilson-MacDonald J, Burt G, Griffin D, Glynn C. Epidural steroid injection for nerve root compression. A randomised, controlled trial. J Bone Joint Surg Br 2005; 87:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/91\">",
"      Carette S, Marcoux S, Truchon R, et al. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med 1991; 325:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/92\">",
"      Genevay S, Viatte S, Finckh A, et al. Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010; 62:2339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/93\">",
"      Loisel P, Abenhaim L, Durand P, et al. A population-based, randomized clinical trial on back pain management. Spine (Phila Pa 1976) 1997; 22:2911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/94\">",
"      Linton SJ, van Tulder MW. Preventive interventions for back and neck pain problems: what is the evidence? Spine (Phila Pa 1976) 2001; 26:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/95\">",
"      Choi BK, Verbeek JH, Tam WW, Jiang JY. Exercises for prevention of recurrences of low-back pain. Cochrane Database Syst Rev 2010; :CD006555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/21/13658/abstract/96\">",
"      Lahad A, Malter AD, Berg AO, Deyo RA. The effectiveness of four interventions for the prevention of low back pain. JAMA 1994; 272:1286.",
"     </a>",
"    </li>",
"    <li>",
"     Moore JE, Lorig K, von Korff M, et al. The Back Pain Helpbook, Perseus Books, Reading, MA 1999.",
"    </li>",
"    <li>",
"     Katz JN, Parkinson G. Heal your aching back, McGraw-Hill, New York 2007.",
"    </li>",
"    <li>",
"     Dunkin MA. All you need to know about back pain, Arthritis Foundation, Atlanta 2002.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7780 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-23B01FB2C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13658=[""].join("\n");
var outline_f13_21_13658=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ACTIVITY MODIFICATION AND BED REST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PHARMACOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Nonsteroidal antiinflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Acetaminophen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Centrally-acting skeletal muscle relaxants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Opioids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other medications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      EXERCISE AND OTHER PHYSICAL MODALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Exercise and exercise therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Spinal manipulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Massage and yoga",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Acupuncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Cold and heat",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      OTHER NON-DRUG TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Traction, corsets, and braces",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Mattress recommendations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      INJECTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/27/7607?source=related_link\">",
"      Acupuncture for rheumatic conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=related_link\">",
"      Approach to the diagnosis and evaluation of low back pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/27/39351?source=related_link\">",
"      COX-2 selective inhibitors: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/43/6841?source=related_link\">",
"      Exercise-based therapy for low back pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22776?source=related_link\">",
"      Lumbar spinal stenosis: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=related_link\">",
"      Nonselective NSAIDs: Overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/62/41954?source=related_link\">",
"      Patient information: Herniated disc (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/47/8950?source=related_link\">",
"      Patient information: Low back pain in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/7/36978?source=related_link\">",
"      Patient information: Low back pain in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/44/40642?source=related_link\">",
"      Patient information: Spinal stenosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41222?source=related_link\">",
"      Spinal manipulation in the treatment of musculoskeletal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39753?source=related_link\">",
"      Subacute and chronic low back pain: Nonsurgical interventional treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/24/19850?source=related_link\">",
"      Subacute and chronic low back pain: Pharmacologic and noninterventional treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/5/34905?source=related_link\">",
"      Subacute and chronic low back pain: Surgical treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_21_13659="FDA resources PI";
var content_f13_21_13659=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F69738&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F69738&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    FDA information for consumers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <p>",
"         Government site with questions and answers about generic drugs:",
"        </p>",
"        <p>",
"         <a href=\"file://www.fda.gov/Drugs/ResourcesForYou/Consumers/QuestionsAnswers/ucm100100.htm\" target=\"_blank\">",
"          file://www.fda.gov/Drugs/ResourcesForYou/Consumers/QuestionsAnswers/ucm100100.htm",
"         </a>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Government site with information about buying drugs online safely:",
"        </p>",
"        <p>",
"         <a href=\"file://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048396.htm\" target=\"_blank\">",
"          file://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048396.htm",
"         </a>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Government site with information about the risks of foreign and Internet pharmacies:",
"        </p>",
"        <p>",
"         <a href=\"file://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/BuyingMedicinefromOutsidetheUnitedStates/default.htm\" target=\"_blank\">",
"          file://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/ BuyingMedicinefromOutsidetheUnitedStates/default.htm",
"         </a>",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13659=[""].join("\n");
var outline_f13_21_13659=null;
var title_f13_21_13660="Risk factors for SSI";
var content_f13_21_13660=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Patient and operation characteristics that may influence the risk of surgical site infection development",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Patient",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nutritional status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Smoking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obesity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coexistent infections at a remote body site",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colonization with microorganisms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Altered immune response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Length of preoperative stay",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Operation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Duration of surgical scrub",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin antisepsis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preoperative shaving",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preoperative skin prep",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Duration of operation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antimicrobial prophylaxis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Operating room ventilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inadequate sterilization of instruments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Foreign material in the surgical site",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Surgical drains",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Surgical technique",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Poor hemostasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Failure to obliterate dead space",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Tissue trauma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        SHEA, APIC, CDC, SIS. Consensus paper on the surveillance of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:599.",
"       </li>",
"       <li>",
"        Cruse PJ. Surgical wound infection. In: Infectious Diseases, Wonsiewicz MJ (Ed), WB Saunders Co, Philadelphia 1992. p.758.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13660=[""].join("\n");
var outline_f13_21_13660=null;
var title_f13_21_13661="Monitoring drug Rx of RA";
var content_f13_21_13661=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F78846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F78846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Monitoring strategies for drug treatment of rheumatoid arthritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drugs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Ongoing monitoring via system review and physical examination",
"       </td>",
"       <td class=\"subtitle1\">",
"        Ongoing monitoring via laboratory tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Salicylates, nonsteroidal antiinflammatory drugs",
"       </td>",
"       <td>",
"        Dark/black stool, dyspepsia, nausea/vomiting, abdominal pain, edema, shortness of breath",
"       </td>",
"       <td>",
"        CBC yearly, LFTs, creatinine testing may be required*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydroxychloroquine",
"       </td>",
"       <td>",
"        Visual changes, periodic funduscopic and visual field examination&bull;",
"       </td>",
"       <td>",
"        None after baseline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfasalazine",
"       </td>",
"       <td>",
"        Symptoms of myelosuppression&Delta;, photosensitivity, rash",
"       </td>",
"       <td>",
"        CBC, aminotransferases and creatinine every 2 to 4 weeks for the first 3 months or after increasing the dose, every 8 to 12 weeks for months 3 to 6, then every 12 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methotrexate",
"       </td>",
"       <td>",
"        Symptoms of myelosuppression&Delta;, shortness of breath, nausea or vomiting, lymph node swelling",
"       </td>",
"       <td>",
"        CBC, aminotransferases and creatinine every 2 to 4 weeks for the first 3 months or after increasing the dose, every 8 to 12 weeks for months 3 to 6, then every 12 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leflunomide",
"       </td>",
"       <td>",
"        Diarrhea, alopecia, intercurrent liver, gallbladder, and renal disease, pregnancy or delayed menses",
"       </td>",
"       <td>",
"        CBC, aminotransferases and creatinine every 2 to 4 weeks for the first 3 months or after increasing the dose, every 8 to 12 weeks for months 3 to 6, then every 12 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minocycline",
"       </td>",
"       <td>",
"        Hyperpigmentation, dizziness, vaginal yeast infections",
"       </td>",
"       <td>",
"        None after baseline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Azathioprine",
"       </td>",
"       <td>",
"        Symptoms of myelosuppression&Delta;",
"       </td>",
"       <td>",
"        CBC and platelet count every 1 to 2 weeks with changes in dosage, every 1 to 3 months thereafter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucocorticoids",
"       </td>",
"       <td>",
"        BP at each visit, polyuria, polydipsia, edema, shortness of breath, visual changes (including cataracts), weight gain",
"       </td>",
"       <td>",
"        Urinalysis for glucose yearly, bone mineral density&loz;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cyclophosphamide",
"       </td>",
"       <td>",
"        Symptoms of myelosuppression&Delta;, hematuria",
"       </td>",
"       <td>",
"        CBC and platelet count every 1 to 2 weeks with changes in dosage, and every 1 to 3 months thereafter, urinalysis and urine cytology every 6 to 12 months after cessation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cyclosporine",
"       </td>",
"       <td>",
"        Edema, BP every 2 weeks until dosage stable, then monthly",
"       </td>",
"       <td>",
"        Creatinine every 2 weeks until dose is stable, then monthly; periodic CBC, potassium, LFTs",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Package insert for diclofenac (Voltaren) recommends that AST and ALT be monitored within the first 8 weeks of treatment and periodically thereafter. Monitoring of serum creatinine should be performed weekly for at least 3 weeks in patients receiving concomitant angiotensin-converting enzyme inhibitors or diuretics.",
"     <br>",
"      &bull;&nbsp;Refer to&nbsp;the UpToDate topic on antimalarial drugs in the treatment of rheumatic disease.",
"      <br>",
"       &Delta; Symptoms of myelosuppression include fever, symptoms of infection, easily bruisability, and bleeding.",
"       <br>",
"        &loz; Monitoring for osteoporosis is discussed in the UpToDate topics on the pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis and on the prevention and treatment of glucocorticoid-induced osteoporosis.",
"        <br>",
"         CBC: complete blood cell count (hematocrit, hemoglobin, white blood cell count) including differential cell and platelet counts; AST: aspartate aminotransferase; LFTs: liver function tests; BP: blood pressure.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Ad Hoc Committee on Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Arthritis Rheum 1996; 39:723; American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the Management of Rheumatoid Arthritis 2002 Update. Arthritis Rheum 2002; 46:328; and Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59:762.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13661=[""].join("\n");
var outline_f13_21_13661=null;
var title_f13_21_13662="Glucose use brain v nonbrain";
var content_f13_21_13662=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76157&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76157&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 565px\">",
"   <div class=\"ttl\">",
"    Glucose use by the brain versus other tissues",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 545px; height: 316px; background-image: url(data:image/gif;base64,R0lGODlhIQI8AdUAAP///4CAgABmM4CzmQAAAICZ/wAz/0BAQMDAwMDN/0Bm/0CMZlBz/yB5TbDQwDBZ/8DZzRBA/7DA/yAgIODm//Dz/zAwMKCz/3BwcKCgoBBwQBAQEPDw8NDZ//D281BQUKDGs7CwsNDQ0FCWc+Dg4NDj2ZCQkCBN/2CA/zCDWWCggJCm/2BgYHCpjZC8pnCN/+Ds5gA28oCpvwBGsnCT5cDW2UBs5gBcWQBSfwA55QAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAhAjwBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wMHCw8TFxsfIycrLzM3Oz9DR0tPU1dbX2NnanwgiQxwZARkcQyEBJiTb6ut6IgEEB0MW8AQWQhj1Gxvp7P3+bwcIwBMSgsAHAB8IhOBAYAMAEwQw/JtIEQ2CgQDeBchIIMDFeB+FIAhAsiRJBBVTqpwSkuNGjSFbjjRJ8sDGlThzJmkJUSI+/xMi6gEoeDAJSZ1Ik4qAaAEBBxIEJiCYQCAd1RAJMyg5mrTryoACCaDMQHWCVgAi5m2QuPWm17dwoXCNS7fukbl289bFq7evV75+A+cELLhwRcKGE2ubWdOt4seLTdo80oGBgcsMKEDeDA1whwgPJCSQ8CCCZs6olQFm8KDCkAoPGKSefQywAQlFJBigzXuY7Q5FEuzuTdyXbdxEdBdfvmt169exmUu/BZgCaNGkTU/fPoswBcuYT3Mf7wox+fOyzKNfX4qxZMfs45tyX3Ky/Put1OPfD0o///+b+AfggJYISOCBkRiI4IKMKMjgg4c4COGEgkhI4YV9WIjhhnO4Z/8fhyD+4SF8IZaY4U0JJGDiinpwVUABS1R2mQGZsWgjGVxdcIISn4U2Wmni3SgkF3OdsEISrLkmBGyyDenkN+GYQA4A4IgzpVFu6XYBErflNtyTQ3IwT0AbkDOmUG0RcUGXRhgAHBHCgenkRfYEhABRCCmUppraFcHmEMrJKaSY9UzAgkuIYimEjJc9ECQASULXpKA2csDCBlRZwIFGiSJxVI/YAUmEdT5m9yil9yGg6qrdOAHRRgmdExEAP4lEU2OQPieEdZPuCh6Np6IqX1jExtNEBvUgME8GUElFFT/04fqnEGsGK+yBJBmaLVtNYLBBVDeRFdVZiroZnAEPXHv/oVhCBFAUjhtNC4BuD7yg7oQbNBWCBcbCm6uSADBpHXL3LohsWCGYcRSpoWonQQRvDgMBBB4A4AEEMDzRwgJQlLAACFJ4DDIZJUyMsREiE9GCCgCUbDIEJYT88RIgLBAzGS9XXETNNyPjTgDeKHzTdzPWKEQBugojgAAjAACBAAM8sYAAUMAwAARSPB01GVMvLUALRWg9BAxQA9C11xwbIfYRaycxgABYk+H10g4U8XbcyJhDAtBCN8FAr8B4PXHZALiwwAh1AzAACIarUPHUDizgOAAgDACDCzBAMMICC7gAgNVYV+7ACCP0LEQJpA9gudiVC9E65Zu3ULHhiJ+u/8LhIHswwOGJDzE1xksL4cHtIxCuuAAZl6yCACrADMDonQux/AJR18y708YLEbkKqh+P9eJCgO+B4dF7sLEKN0Pf/Oe3o19E8CAIkDbqnMOdDD5ifXBoGfoxCuyivzKaLQSQAg00wAFla8HXile3paWgAcwzG/MU2LSpaQBuA+De1EAgtqk1IAUCaAARYKABDewObh2kmgSPN4IBNAACCmwBA8mWggw2rYADAKHpfleCEAoBhCszXgOaNoS3bQ2BI4ghAEDYAI4l0YXIa9vzCAhF7wFAfkLA4tRa0AINLNGEBYRB/FrYQhLWsITvo5oLIkhCE/4uGRtgQVMC0K8xqP8HVA8zgGlA9aM+1UJ+8Zta1DSQAosx7Yoc84AWVQhCCepsfCMA4dXKNrUfqjB8AgDZ3VIohEoaUHgeIKQhSxfCFrjAAz2k3vK21kmvaSBmPWTZ2hDYu+NtrXgVKyD2tma1BUBwcKyUYMYqeTdEZtFmEfxcD8GGQBessYYgW6MG7TeEuaVgdpm0IjLEcgAEsKCOYlBPpOZlgBP8LWlMusUiy4ZFY7Zzka1c4Q814EyocVKemPweCimpwkq285gAjdwFU/A06qkObxJUoABiJra1qcCLRDBiPFcoNjOCYHnAJEIlV1jMdy6gbQ0t2wm/9jbuqS5j1fxaCCtWzGIi4wD/FphAQkwQhhEpYVoMiMBlCCaEQP2RY08rGwPf5jmPShACa6zgJUMIQ3vyc6LaYxoEfie24iXxggAongs0pzkBOICoEFCBAyCAxhJy0AUjayUE3tYAD4TyhQqMmiLBFlHCrXEASMQe4p42gqnuM5hxdQAErXjBIHKshA5wQCEN2NUSuKAFEBhjD1Mw1haYLnhTaxpf/YrQYojgW/W4khdsmgRzvUanph1CnAaYtlVarHgaoKtRLSi/x10yfvJzatQ2utEhKJCQf20ZBCNJteFdsAEw8ABswQYDEBIQlsULYS3fCEKWgeCCgiwc8uxmvC4yTWcWBMDygJvRIXjAg4Mt/+Z1Y4tF1C2NYyVgIsgEu7QRVEyxDkRpFqlGwmz+FoSdNUarzqAeea1gp17yylbxq7M6NJEMYoysKB+DAaBhSrThJBERxhmwBzQKYOnsCgQJWMs56C7AXijBBZlmOsNsIAMf0Ae37KjhITCsj59BV8OsVTDpiEWmdOybEogWHnKeoGg87jFzZNoRDIAzDBoCwApOADAlrwci+5jAjDNcBRSky8rQoK90AyECEnDAKUKmwgNQAGZnIHBuXv2Dkw9A5y1DucZOqICR2syMEc9NhH4Ai0CeDIYoD+EzPOWzMeDstUFMIGH8w/MTHpZkRfuC0cETBL9Geys6SvoJL0iapf+H4WevAboPc57Hu7YQLU9rQQFsHjUx3jy3EutB0BMImr+yUIEIbEnWwxDzAVlhaCMkAGLAvlGxjTDlKic7RMs2wt+evaJoF0HPR6I2avTGt0h74TMq0jZk8IcA/aWZCxeIgLPFHb4LmrAucZwjob9g7SOgQAHsLsIa5+a5uHDTm/POAmm9ABt75VsIpfZhXGDKZJqCYeBesM6vnXExk1VOdRjPuMY3zvGOe/zjIA+5yEdO8o5juuQoT7nKV75yFPPhswLR1Lm9oCVgTOziA9gc58723p23kOVAD7rQhx7ykxP96EhHusv7MOCZe2FNE19FyT7OuRE30aCLy1kyEn7/6rdU+LMTwPCdyQB1U0x9YxBsYgs8zsGlO2PfXus3XF4c47U4/Qtl98Tl0B7CBazdeSsZgLuD+ZYffyDI3i5D3jHhAQeooAEaaCHgDw4JJgfAyXcHw+InsVYQ1tDtlGcElkmg5cxr3gBRb4QHQDACA4q1waG3RJnPLHYlVOkmVRrHEur9hM0rwvHyw1zsOeEOdEAB5geYgBDOZI89ocH3hShBFxsg/OFz4mAN0TUTqKJrPCUE0p769OlTH4jLQd6y1v/EBj5wJwusWglBmQBVDsIpTgGg1R9KA/T5sPqpidUawmZr+MEuGRFwRUAnykIA4dARiYJ/4hcG+3cHq2dV/yAAe9NAa14jgPIRU5dnd00QFPGgET1BKwTgcOHnBhH4BQHYBBPINBUYCCsoCQmncP8Bc6H1BFcxDwjQLFNRFc7HBinIBRhIN0nQgiPwgoIwhHFWBi5gdXI3Bph2SfxBAqxSe0iQFg1xFuJiFrv3gGMQhFowg103BKznghYYCGJYBm8DZ4QHBlE4IO5HJYZies+HelCIaWHjS0h4CG9IBis2NxA1BmkIIASIeLsGB2B4BX34OQtAT4ywiGIAiWGghBoYHxvgcB/wfmMnB4lYBWkIAw81AGe4BTFIBoM4Bn/oSmZQiv/BAvWwLHSoBp04BUpYORqgAvqlgoxWiUK4i/9qyGhtCGaW0hB2tolzMItSIGyNuAC5CAanOAasOAZNuDTUl35ewHtbgIy02ESgtwWSaI2FMGd1VlPvcQfa+AQwoIdo8I3gOAiChhFfAHFn4D8CNATnuAS6AzWjKAbP2I6I8Gix+AV8ZCpGAH3RmASCxYxrQIn+uAiblnhowGEhVgSbx5BKkI7D1gYH2ZCBkGoGEZBeIC8+RZF2iHCMNoZEkI+iyJG7gGvax2VpkFpCsFpH8DAwckV4eAQJ2YwsSRHY6AQi+SWU8QAKUAHfaFy82JOx0GnkQmNqIJHRoQQVgAIncAMnGTZNtI9KOQvEEhYGSCReyAU3RpBMsAIxgAP/cFZLgveEW4kLrLIqL2mMaEBk/+MExzYD1Ng78ZUCLdaWuSACbwmSdQAbouYC7+aXvvCODcEPMCkIKBABKnJeL4SYv3AALJAtMbY/WuCAhZBuNHCLWkmZtrABKJERH4B5rNZp+ScIMpADNrBuopkL+dJ+NvGVWfCTaCB4NaAADxAxsakL74Aw5uaUg/B4N1MAEZBov3kLMxGXcukHynVNyREBDACby7kOuDkGHpACC3CGFfACEZBt1+kP2RkG8cUySZAAJ6AAlTae1FCeX6BidCWVyHmT7gkLtIdmELkHDqABINMBCjAjCuCbh/YAvXmfrnAwylKM9BaWQmh1SQkA/11UN8KhANgRoOFmBPVpnQg6ChMQUyNhm1oAnwjpi0hwXnwpBOZUBAywI0hAAQpwAhnaoabwb6gZj+WYBv04BCo2OUIgkwBAk0iwAhHwAhxKo51gKBYQAB6Io/XhoFrAjmvElgYwo0EqlEhQATlFfkjqCQUhEPsgmFwgicbVlyu6YS7KBBKwnlbapZ1QfIx5iGfwjPHVnUdQoRdapU9QAciJAu3pppIAmKwipqRoos8TWzwSoJcxoFJAAY9ZAEfKBQAqoAQKqGmgmGFKnGlQivGTVmOQADHKpV2Ap6OBoZbKBpaJmXEkp2/QqfrHpmJwpkPQoqe6BqTZLqcpoldAov9Q4KpqwKcR4KdgAKRCWqtmMJv7Upusyga+Kgb0KB6OGgGQGpJWWqxfMJWoFayRugXPKmvBKRBYoZlMAJj8kHtWOAS82gTNGgYDKSqqFapdIKtCQKtiABvhmSJEKmpg0K5+pGjNGQUwdxPM14Wtmk1kAJWAAwAXUBov8KdNQKoSYKpiQJVVpmexJgYIWwbdOiCC2nRNMA8M6H16cn+qCaVdsK5iEJRI0AEoQCPKOQWTuqiVGpLktyZkoLJjwK8Oyx34M2hPwKT48BIMaH+cyawGWwbEiqXXNmVGsq11oKfncrMEaq1ekLH/sQEBEQCl94EKUX9Dy4CKsgYoOwY4uwT/EmAZKDCzeFCSaqK0IZloIzmscOu28SEWBLApmugpXSkrPlGCP3gGKuapZWC1TUAB4PkAF+C0b0CxRGCxB4tOUZmyU0u37KEQB/ABD8kEVOhNBMACJMCDz/K3ZRC4ajCW7goFF6AAwaq2cmCvK4CvoKG4VmC6/Sq3CfYfFfalTdkE9reFu2sE6VoEoRSMZUCX9RgFhnsCTYsH2HoZ2moGxruzVkC4ACICzlloJmsF24meinC2LgsNtCu902EfGJC3DXoG2/sIFcC0DesM0fsfezMBNhEAmaupZKAC0hkJLBsBClAACSC+xlpTXQm2ywoG+Buai1ABF3Bvi4oC/gvA/wGcBWdmASygKtd7vmQgeAgMCRSQAAXAwAYAaw8cwY0gj19wXX3JCR38wYoqwv+bEhsLFxkAWvDIaU8Kja+UCisMwiL8uimiDjobF99CZwfAoNeYvU9Auq+wwizMmzNClCJcAD7MusZAvY2QIlicxVqsxSvwIl78xW3KB01KYEjMgjXEC1jcxQXAAAqgus7bxgzwxXI8x3Rcx3Z8x3icx3q8x3zcx3RMI3JsGX48yHR8b218yIicyIfsYTPSyI78yFCsyJJ8yA5cx2G8BxggroQaBaSTDB2Ar4QcyqI8yqRcynVsAJXsxS1ryn7sw1v8ylk8C++oq1hQnjm0wZZWtv9eIY5FvMlO0J8pTG1W3BX5ea5dgJsqFqGyFr5xoaAWYMTHXMYnesbD975x8aFSYYj2mwWdTMLUYKO0vKvSbAS37M3UoKRAa8M0sZpWAMzm7AgxzAdfupjqnKNYkMzv3AhB7AdwSsZZ4AENQLz5XAjDjAfuAgAkcADgt81UIDkD3Qi6rAcvJgTf5MtGcMAPzQhJ6weFGM5WsGzXxZMZbQgRnQcWYAEhEAJj3JhT0EPBPNKEUNB3MM+ZWsBOQEKCC9OHwMx+sDfGZ9EWkwLcq9OKYM2oBs3YSwXLk5dE/QwVnQYasoa11tTNYAIbUBK/m9QICaFRdZVUvQyzTI43jAT/lKhi7BgLWay4CmBwUbDWxYvFlQqgUfcCbNbBWjwFbp2ootoFn5wip5K6VFwNHeuxXWDCQyCGKaBQjIYLjQyZTVAAe31T+EYGBdDIX6ZaBmCfFJDZAFDZjswlk30EIbwEwmGfYqCol8HWRwO168ABTiYCH7DQLJ1GjMYxOyoLlwEAL8DZF1AAFLACHczGCpBtkB2kBSAB95ZoU9m//gsAo+3BmgHdQXpvaTsvbJxt39nGN5m6w10ElQ2pHqYiyy3IQ1DZmtHBB/YAP8yya+0aa3ICvp0Awp1to00ElRHH8c3Zxd3Zv3YBbGykUqYADIAc7M0AW8KnAp5oGLrZw1EZ/23M2uqQEGLBAuZ7xEkQhfdlqLVwGUhzApoRoDrlwQ4coFsy2pXNv5cRJB5G15xt4npa2SmCLgXQv7rBALttLycgrS+wIzduGeLZ2ZmtZwagGSu+ykMgrxW6K6CBnOmy2/zbAR8843ZY30ourRha2s492S4exzLa47ex2Q/wwbJRGkgjkxjaAeUEANZh5RC+DSXYTdo820RwihuJ2yF8ZDASoEqyvqzR4vgG47rN2sLBZlju4ioC45ZxGkTjGqUBABEQrL7t6PBd2aEN5DOyJWhO6JxNTjyV5FLWJbsNHPXN5x4GI1QO5FsC44Wu5fgWAS5aAb2WLhVAI2h+Ai+wAv8VgOb9a+RDgNrIdmCp3ubaYLkIcLmmZ5HAkNvOvRsBOgSlsQIHZup//uKCztmrDuSHXqXN3uvD0eyVcWSmUU5eHHWV/ZgGcCRYjuUA8JjnMtmADuj1/ezRnuVE8O5Veu30fur1PdoRq1PqHcJePKMButvmYu+XfA2XgikKSId1vguXkQAHtiPb7txd7ufYfvFLUk4JsNvS/ulhfmQQj8oeLMWZXeMAoAAXAKpuIsgJ0Nv1ntnC4Sa9VvEwMuuqfaWTjeYMoJ4R8KMyutk0T++AQiMqH+MwolMsjm8+Lt/yfRuV/booIBqP7ui+BvFRh6GVTWXCsfMS29oJsdKNWYr/LZC/wtDIjDrxaxLCFm/wfKL2HV8BARobLw7uuAGeNOIa4HECB27u0vryMLLbrZFubv/pj+LpCntkB2rpHZD2AdrxRODk4Y3l6Vako928Hq6lemQvFMDIB8ooJ8BTpuphbAb5wu4VJGAC5zAl5kqwU5SWh/rS65DyTf+ycLCeZfC6pGEAsjsbIXC5pQkFgtZ8A7snYhhKyqwNLSvud8CnB88FR6Zj6BEUYRGnTbAQHEAVd/KR37cnUeh3X40NTJrSV00Fz+K1N1G0UUj23/+exsLOTTCC5m8rt2IfM7hQ638N3+qVUIAP+wMEJgIGgCGYAEnlMhBIOgRRqWtZtV6x/1ntltv1fsFh8ZhcNp/RafWa3XazAwT5/PD9ECZNBAmPmBBItJqUHBqkFt4SFRcZGx0fISMlJynd5uScMv4mMrYGqxw0PCpJS01PUVNVV1lRP5U8NBxaaWttb3FzdXe7XpNGRniFh4mLjY+RmZyUQESTn6GjpaepxV5BBGart7m7vb9ZP6FAwMvNz9HTxz4bqNTf4ePloRGamg6cQBrm+fv9/1PVs4cPgANtABEmVLgQzjKGDyFGlGjF10SLFzHGq5iRY0eP0zZ+FDmSJK6QJVGmVDlpY6EoDQ6ulDmTpjWHT6RIiVmTZ0+fFQ3lFLDPZ1GjMisKlXKUaVOLAu3du/8JQGkUp1exJoQaleCSoDmJZhU79l9FKEJ3klW79lzLoDDZxpUL7uRcu3e31cW7l+8xvX0BBzY5VXBhw7T+Hla8OFJixo8hu3EcmXLlL1u7Wta8OQxmwpxBh84yWXRpy6RNp36MWnVrw6xdx+4LW3Ztu7Rt516LW3fvrLx9ByfJIUOADBw8fRa+nKcFAgcIWEjOnLrPEAQ+ALgTIsnWgfiihhc/nnx58+fRp1e/nn179+/hx5c/n359+/fx56ePIFkcJ/67G+8A8PRLb8AC0TsQQfMUXLC8Bh0UD8IIv6OQvAktvIfADDXkMLzMjAEQwNGUcwS4Mk4kI0UVS1xkxTD/XrSpkhjBoLHGFnURgggjkCCRFBu9ALIXHBURkgsjBSEyESSnY0nJN5h0hI8J/AAkyR+fbCNKLLbkMsuGnJzxSzDDpKRLRjTBo5MrxTRzTDXOpOjNNOJUok5l2ixTz3LuxHNPSPpMItA+AwWg0EHnpDPREBdFA1E385SE0EbNOJRSFiPl81IUN5XxT0A7hTHULyzNFFRTvynU0FFJZTVIV1+FVFJYh0TVRFqPxJUWBPirhFdKfp0kWGF7lWRYSI6NJFlki1W2WWeri1baaamt1tprsc1W22257dbbb8ENV9xxya2GOOOQ64YEEwIwId1zj6tGhD2SgDddaM5dxl5q/851t97i4pUGARGU2DeJENoNJB3noJOuG+jkcJjh6KgRYQMClpnY4Wcsfm6CJDSehoOJN0AuZGhEiKMOkJ+juIjoNthAYXOuy267bkLggIM/EKhZOwK4k8Y5jAHw+eZn/iD4YOx+DpoeiqHrmemjk4F4ZaOB5oCADQDQER0Rif7mDxLA1lXSDYz4j+gRkREBjz+yK1uakaObgAVD1w77GQSeEzTvAPiuI/Cv//7Ga7lRBlputo/h2wIEnCuu8Gg4YGGDPyzgAPG9+8ZbbcD7Hvwcr3n0xoi7ux7i5R6fieOSdlUvPRm36/CP9COkEcKJO2DfEfenV77dBLel8/mcKf+rnLmaO/IAHPmxoyGBVxYIYIGE561EGmjn9ugD+mgyiA5yAjLAXvljRBDicQ7MB+CPEO5Y85w0OfHmEqLpl1+aEfOPRgTnNrCm/k0DAxfLQxIG+AyIyYE/A/zf1ohQLglOkIIVtOAFMZhBDW6Qgx304AdBGEIRjpCEyOAVr+6lhQNEMA0ZOIDSrLBCMIjgAPorYQUvsYFnXaFzaajH+ZTQwyRAJwt8M9sNeyOHly3DBAf4gNMCcADqHUBznSCb064IgB92zQmacyJ3tlg58PDnOU1kAQeqBLgrGLFoASBYCKSoKiRSBhMWmEAgjICBmxnhAypzH9eEoL8NSId67mL/mgU2EADnpIwA/HEOBqjnhIj9gQUZuFgN14gxvt3tOhYIwB/mCC45HOAPThgkALSWncsloW9xCAEiq0A9DgzyANfJAO0CEMk48Kp6WiRa37RWByJigW8FzBwAoBOIYYayW0oEgBI717do1oEPj6xC+IwQPlkGzh71aCQb2ThNZBKgiFuLGXKGuUxmbouBQvjYduKABOiEIHwrgxgM6yWH7EQsCTHLAAJMIDkEaI1KaXvmyvo2T4JtYGXdGYIQspO2EIByndy6xAtReQe0JUEEf4DOysK3sSXcAQkk5egd8ICwRgLAki2TJELrEIKLDY98S2AjdNwFnQlQtKIczKYaX/6JAKplwQQf2wIJ/mlJkfY0g+dUA/XwoKQAOC0LHcMOPpmaVa1ulatd9epXwRpWsY6VrGU161nRmla1rpWtbXXrW+EaV7nOla51tetd8ZpXve6Vr331618BG1jBQiMIADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Estimated percentage of glucose rate of disappearance (Rd) used by brain and non-brain tissue from infancy to adulthood (n=141). The tissue data points represent the mean values for subjects with body weights, in kg, of 0.5-1.0, 1.1-2.0, 2.1-3.0, 3.1-4.0, 4.1-5.0, 5.1-10, 10.1-15, 15.1-20.0, 20.1-30.0, 30.1-40.0, 40.1-50.0, 50.1-60.0, 60.1-70, and 70.1-95.0, respectively.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Haymond, MW, Sunehag, A, Endocrinol Metab Clin North Am 1999; 28:663.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13662=[""].join("\n");
var outline_f13_21_13662=null;
var title_f13_21_13663="Bifurcated modular aortic endograft";
var content_f13_21_13663=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bifurcated modular aortic endograft",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 184px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is a representation of the Talent bifurcated, modular endograft.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     World Medical/Medtronics. Santa Rosa, CA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_21_13663=[""].join("\n");
var outline_f13_21_13663=null;
         